| Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
| 1 |
100000 - Document - Document and Entity Information |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DocumentDocumentAndEntityInformation |
| 2 |
Implied Table |
Table |
* |
* |
implied:Table |
| 3 |
Document And Entity Information [Abstract] |
Abstract |
|
|
nept:DocumentAndEntityInformationAbstract |
| 4 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
| 5 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
| 6 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
| 7 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
| 8 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
| 9 |
Trading Symbol |
Concept (Text/String) |
For Period |
|
dei:TradingSymbol |
| 10 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
| 11 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
| 12 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
| 13 |
Entity Current Reporting Status |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
| 14 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
| 15 |
100010 - Statement - Consolidated Statements of Financial Position |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/StatementConsolidatedStatementsOfFinancialPosition |
| 16 |
Implied Table |
Table |
* |
* |
implied:Table |
| 17 |
Statement Of Financial Position [Abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
| 18 |
Assets |
Abstract |
|
|
ifrs-full:AssetsAbstract |
| 19 |
Current assets: |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
| 20 |
Cash and cash equivalents (note 24) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 21 |
Restricted short-term investment (note 24) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentInvestments |
| 22 |
Trade and other receivables (note 5) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherCurrentReceivables |
| 23 |
Tax credits receivable (note 18) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTaxAssetsCurrent |
| 24 |
Prepaid expenses |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentPrepaidExpenses |
| 25 |
Inventories (note 6) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
| 26 |
Other financial asset (note 21 (a)(iii)) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentFinancialAssets |
| 27 |
Total current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
| 28 |
Restricted short-term investments (note 24) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:RestrictedCashAndCashEquivalents |
| 29 |
Property, plant and equipment (note 7) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 30 |
Intangible assets (note 8) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 31 |
Goodwill (note 8) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Goodwill |
| 32 |
Tax credits recoverable (note 18) |
Concept (Monetary) |
As Of |
Debit |
nept:TaxCreditsRecoverableNonCurrent |
| 33 |
Deferred tax assets (note 18) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:DeferredTaxAssets |
| 34 |
Other assets (notes 13 and 21 (a)(i)) |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherNoncurrentAssets |
| 35 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
| 36 |
Liabilities and Equity |
Abstract |
|
|
ifrs-full:EquityAndLiabilitiesAbstract |
| 37 |
Current liabilities: |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
| 38 |
Trade and other payables (note 9) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
| 39 |
Loans and borrowings (note 10) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentPortionOfLongtermBorrowings |
| 40 |
Deferred revenues |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredIncomeClassifiedAsCurrent |
| 41 |
Total current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
| 42 |
Deferred lease inducements |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RentDeferredIncomeClassifiedAsNoncurrent |
| 43 |
Long-term payable (note 11) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentPayables |
| 44 |
Deferred tax liabilities (note 18) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NetDeferredTaxLiabilities |
| 45 |
Loans and borrowings (note 10) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 46 |
Unsecured convertible debentures |
Concept (Monetary) |
As Of |
Credit |
nept:UnsecuredConvertibleDebentures |
| 47 |
Other financial liabilities (note 21 (a)(ii) and (iii)) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherNoncurrentFinancialLiabilities |
| 48 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
| 49 |
Equity: |
Abstract |
|
|
ifrs-full:EquityAbstract |
| 50 |
Share capital (note 12) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
| 51 |
Warrants (note 12 (e)) |
Concept (Monetary) |
As Of |
Credit |
nept:Warrants |
| 52 |
Contributed surplus |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AdditionalPaidinCapital |
| 53 |
Accumulated other comprehensive income (loss) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccumulatedOtherComprehensiveIncome |
| 54 |
Deficit |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
| 55 |
Total equity attributable to equity holders of the Corporation |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAttributableToOwnersOfParent |
| 56 |
Non-controlling interest (note 13) |
Concept (Monetary) |
As Of |
Credit |
nept:NoncontrollingInterestsExcludingSubsidiaryWarrantsOptionsAndOtherEquity |
| 57 |
Subsidiary warrants, options and other equity (note 13) |
Concept (Monetary) |
As Of |
Credit |
nept:SubsidiaryWarrantsOptionsAndOtherEquityNoncontrollingInterests |
| 58 |
Total equity attributable to non-controlling interest |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncontrollingInterests |
| 59 |
Total equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 60 |
Commitments and contingencies (note 23) |
Concept (Monetary) |
As Of |
Credit |
nept:CommitmentsAndContingentLiabilities |
| 61 |
Total liabilities and equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
| 62 |
100020 - Statement - Consolidated Statements of Earnings and Comprehensive Income |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/StatementConsolidatedStatementsOfEarningsAndComprehensiveIncome |
| 63 |
Implied Table |
Table |
* |
* |
implied:Table |
| 64 |
Statement Of Earnings And Comprehensive Income Loss [Abstract] |
Abstract |
|
|
nept:StatementOfEarningsAndComprehensiveIncomeLossAbstract |
| 65 |
Revenue from sales (note 4) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 66 |
Royalty revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromRoyalties |
| 67 |
Total revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
| 68 |
Cost of sales (note 6) |
Concept (Monetary) |
For Period |
Debit |
nept:CostOfSalesExcludingImpairmentLossOnInventories |
| 69 |
Other cost of sales - impairment loss on inventories (notes 4 et 6) |
Concept (Monetary) |
For Period |
Debit |
nept:OtherCostOfSalesImpairmentLossOnInventories |
| 70 |
Cost of sales (note 6) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
| 71 |
Gross margin |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
| 72 |
Research and development expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
| 73 |
Research tax credits and grants (note 18) |
Concept (Monetary) |
For Period |
Credit |
nept:ResearchTaxCreditsAndGrants |
| 74 |
Research and development, net |
Concept (Monetary) |
For Period |
Debit |
nept:ResearchAndDevelopmentNet |
| 75 |
Selling, general and administrative expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
| 76 |
Other income - royalty settlement (note 14) |
Concept (Monetary) |
For Period |
Credit |
nept:OtherIncomeFromRoyaltySettlements |
| 77 |
Other income - net gain on sale of assets (note 4) |
Concept (Monetary) |
For Period |
Credit |
nept:OtherIncomeNetGainOnSaleOfAssets |
| 78 |
Income from operating activities |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
| 79 |
Gain on loss of control of subsidiary (note 13) |
Concept (Monetary) |
For Period |
Credit |
nept:GainOnLossOfControlOfSubsidiary |
| 80 |
Finance income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncome |
| 81 |
Finance costs (note 16) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 82 |
Change in fair value of derivative assets and liabilities and loss on sale of available-for-sale investment (note 21) |
Concept (Monetary) |
For Period |
Credit |
nept:GainsLossesOnChangeInFairValueOfDerivativesAndLossOnSaleOfAvailableForSaleInvestment |
| 83 |
Income (loss) from non-operating activities |
Concept (Monetary) |
For Period |
Credit |
nept:ProfitLossFromNonoperatingActivities |
| 84 |
Income before income taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
| 85 |
Income tax recovery (expense) (note 18) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 86 |
Net income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 87 |
Other comprehensive income (loss) (that may be reclassified subsequently to net income) |
Abstract |
|
|
ifrs-full:ComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTaxAbstract |
| 88 |
Unrealized gains (losses) on available-for-sale investments (notes 13 and 21 (a)(i)) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnRemeasuringAvailableforsaleFinancialAssetsNetOfTax |
| 89 |
Net change in unrealized gains on derivatives designated as cash flow hedges (note 21 (a)(iii)) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnCashFlowHedgesNetOfTax |
| 90 |
Reclassification to net income of accumulated realized gain on available-for-sale investment (note 21 (a)(i)) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReclassificationAdjustmentsOnAvailableforsaleFinancialAssetsNetOfTax |
| 91 |
Total other comprehensive income (loss) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax |
| 92 |
Total comprehensive income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
| 93 |
Net income attributable to: |
Abstract |
|
|
ifrs-full:ProfitLossAttributableToAbstract |
| 94 |
Equity holders of the Corporation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOwnersOfParent |
| 95 |
Non-controlling interest (note 13) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToNoncontrollingInterests |
| 96 |
Net income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 97 |
Total comprehensive income attributable to: |
Abstract |
|
|
ifrs-full:ComprehensiveIncomeAttributableToAbstract |
| 98 |
Equity holders of the Corporation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent |
| 99 |
Non-controlling interest (note 13) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests |
| 100 |
Total comprehensive income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
| 101 |
Basic and diluted income per share |
Concept (Share) |
For Period |
|
ifrs-full:BasicAndDilutedEarningsLossPerShare |
| 102 |
Basic weighted average number of common shares (note 19) |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
| 103 |
Diluted weighted average number of common shares (note 19) |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
| 104 |
100040 - Statement - Consolidated Statements of Changes in Equity |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquity |
| 105 |
Statement Of Changes In Equity [Table] |
Table |
* |
* |
ifrs-full:StatementOfChangesInEquityTable |
| 106 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 107 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 108 |
Share Capital |
Member |
|
|
ifrs-full:IssuedCapitalMember |
| 109 |
Warrants |
Member |
|
|
nept:WarrantsMember |
| 110 |
Contributed Surplus |
Member |
|
|
ifrs-full:AdditionalPaidinCapitalMember |
| 111 |
Available-for-Sale Investment |
Member |
|
|
ifrs-full:ReserveOfGainsAndLossesOnRemeasuringAvailableforsaleFinancialAssetsMember |
| 112 |
Cash Flow Hedges |
Member |
|
|
ifrs-full:ReserveOfCashFlowHedgesMember |
| 113 |
Deficit |
Member |
|
|
ifrs-full:RetainedEarningsMember |
| 114 |
Total Attributable to Equity Holders of the Corporation |
Member |
|
|
ifrs-full:EquityAttributableToOwnersOfParentMember |
| 115 |
Subsidiary Warrants, Options and Other Equity |
Member |
|
|
nept:SubsidiaryWarrantsOptionsAndOtherEquityNonControllingInterestMember |
| 116 |
Non-controlling Interest |
Member |
|
|
nept:NoncontrollingInterestsExcludingSubsidiaryWarrantsOptionsAndOtherEquityMember |
| 117 |
Total Attributable to Non-controlling Interest |
Member |
|
|
ifrs-full:NoncontrollingInterestsMember |
| 118 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
| 119 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
| 120 |
Acasti |
Member |
|
|
nept:AcastiPharmaIncMember |
| 121 |
Statement Of Changes In Equity [Line Items] |
LineItems |
|
|
ifrs-full:StatementOfChangesInEquityLineItems |
| 122 |
Beginning balance, shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
| 123 |
Beginning balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 124 |
Net income (loss) for the period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 125 |
Other comprehensive (loss) income for the period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncome |
| 126 |
Total comprehensive income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
| 127 |
Transaction with equity holders recorded directly in equity |
Abstract |
|
|
nept:TransactionWithEquityHoldersRecordedDirectlyInEquityAbstract |
| 128 |
Contributions by and distribution to equity holders |
Abstract |
|
|
nept:ContributionsByAndDistributionToEquityAbstract |
| 129 |
Share-based payment transactions (note 17) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions |
| 130 |
Liability settled in shares, shares |
Concept (Shares) |
For Period |
|
nept:LiabilitySettledInSharesShares |
| 131 |
Liability settled in shares (note 12 (b)) |
Concept (Monetary) |
For Period |
Credit |
nept:LiabilitySettledInShares |
| 132 |
DSU released, shares |
Concept (Shares) |
For Period |
|
nept:IncreaseDecreaseThroughDeferredShareUnitsReleasedShares |
| 133 |
DSU released (note 12 (c)) |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseThroughDeferredShareUnitsReleased |
| 134 |
Share options exercised, shares |
Concept (Shares) |
For Period |
|
nept:IncreaseDecreaseThroughExerciseOfOptionsShares |
| 135 |
Share options exercised (note 12 (d)) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions |
| 136 |
Loss of control of subsidiary (note 13) |
Concept (Monetary) |
For Period |
Debit |
nept:LossOfControlOfSubsidiary |
| 137 |
Total contributions by and distribution to equity holders, shares |
Concept (Shares) |
For Period |
|
nept:IncreaseDecreaseThroughTransfersAndOtherChangesEquityShares |
| 138 |
Total contributions by and distribution to equity holders |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesEquity |
| 139 |
Change in ownership interests in subsidiaries that do not result in a loss of control |
Abstract |
|
|
nept:ChangeInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControlAbstract |
| 140 |
Expiry of Acasti options and call-options (note 13 (i)) |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseThroughExpiryOfSubsidiariesOptionsAndCallOptions |
| 141 |
Acasti public offering (note 13 (vi)) |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseThroughSubsidiariesPublicOffering |
| 142 |
Acasti issue of unsecured convertible debentures, net of deferred income tax expense of $129,362 (note 13 (vi)) |
Concept (Monetary) |
For Period |
Credit |
nept:SubsidiariesIssueOfConvertibleInstruments |
| 143 |
Exercise of warrants, shares |
Concept (Shares) |
For Period |
|
nept:IncreaseDecreaseThroughExerciseOfWarrantsEquityShares |
| 144 |
Exercise of warrants (note 13 (ii)) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity |
| 145 |
Fees related to past financing of Acasti (note 13 (iii)) |
Concept (Monetary) |
For Period |
Debit |
nept:FeesRelatedToPastFinancingOfSubsidiary |
| 146 |
Convertible debenture interest settled in shares (note 13 (iv)) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
| 147 |
Total changes in ownership interest in subsidiaries |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries |
| 148 |
Total transactions with equity holders, shares |
Concept (Shares) |
For Period |
|
nept:IncreaseDecreaseThroughTransactionsWithOwnersShares |
| 149 |
Total transactions with equity holders |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners |
| 150 |
Ending balance, shares |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
| 151 |
Ending balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
| 152 |
100050 - Statement - Consolidated Statements of Changes in Equity (Parenthetical) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/StatementConsolidatedStatementsOfChangesInEquityParenthetical |
| 153 |
Statement Of Changes In Equity [Table] |
Table |
* |
* |
ifrs-full:StatementOfChangesInEquityTable |
| 154 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
| 155 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
| 156 |
Acasti |
Member |
|
|
nept:AcastiPharmaIncMember |
| 157 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 158 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 159 |
Unsecured Convertible Debentures |
Member |
|
|
nept:UnsecuredConvertibleDebenturesMember |
| 160 |
Statement Of Changes In Equity [Line Items] |
LineItems |
|
|
ifrs-full:StatementOfChangesInEquityLineItems |
| 161 |
Acasti issue of unsecured convertible debentures, deferred income tax expense |
Concept (Monetary) |
For Period |
Debit |
nept:DeferredTaxExpenseIncomeDueToIssuanceOfUnsecuredConvertibleDebenturesBySubsidiary |
| 162 |
100060 - Statement - Consolidated Statements of Cash Flows |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/StatementConsolidatedStatementsOfCashFlows |
| 163 |
Statement Of Cash Flows [Table] |
Table |
* |
* |
nept:StatementOfCashFlowsTable |
| 164 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 165 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 166 |
Acasti |
Member |
|
|
nept:AcastiPharmaIncMember |
| 167 |
Statement Of Cash Flows [Line Items] |
LineItems |
|
|
nept:StatementOfCashFlowsLineItems |
| 168 |
Cash flows (used in) from operating activities: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract |
| 169 |
Net income for the period |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 170 |
Adjustments: |
Abstract |
|
|
ifrs-full:AdjustmentsForReconcileProfitLossAbstract |
| 171 |
Depreciation of property, plant and equipment |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDepreciationExpense |
| 172 |
Amortization of intangible assets |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForAmortisationExpense |
| 173 |
Stock-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
| 174 |
Impairment loss on inventories (note 6) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss |
| 175 |
Gain on loss of control of subsidiary (note 13) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesRecognisedWhenControlInSubsidiaryIsLost |
| 176 |
Recognition of deferred revenues |
Concept (Monetary) |
For Period |
Credit |
nept:AdjustmentsForRecognitionOfDeferredRevenues |
| 177 |
Amortization of deferred lease inducements |
Concept (Monetary) |
For Period |
Credit |
nept:AdjustmentsForAmortizationOfDeferredLeaseInducements |
| 178 |
Net finance expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForFinanceCosts |
| 179 |
Realized foreign exchange gain (loss) |
Concept (Monetary) |
For Period |
Debit |
nept:AdjustmentsForRealisedForeignExchangeLossesGains |
| 180 |
Net gain on sale of assets, excluding transaction costs and severances (note 4) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets |
| 181 |
Charge on settlement of liability |
Concept (Monetary) |
For Period |
Debit |
nept:ChargeOnSettlementOfLiability |
| 182 |
Income taxes expense (recovery) (note 18) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncomeTaxExpense |
| 183 |
Tax credits recoverable (note 18) |
Concept (Monetary) |
For Period |
Credit |
nept:AdjustmentsForTaxCreditRecoverable |
| 184 |
Adjustments to reconcile profit (loss) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForReconcileProfitLoss |
| 185 |
Changes in operating assets and liabilities (note 20) |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperations |
| 186 |
Income taxes paid |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities |
| 187 |
Cash flows from (used in) operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperatingActivities |
| 188 |
Cash flows from investing activities: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract |
| 189 |
Maturity of short-term investments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromDisposalOrMaturityOfAvailableforsaleFinancialAssets |
| 190 |
Acquisition of short-term investments |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfInvestmentProperty |
| 191 |
Proceeds on sale of assets (note 4) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets |
| 192 |
Proceeds on sale of investment (note 21 (a)(i)) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromSalesOfInvestmentsAccountedForUsingEquityMethod |
| 193 |
Interest received |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestReceivedClassifiedAsInvestingActivities |
| 194 |
Acquisition of property, plant and equipment |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| 195 |
Acquisition of intangible assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities |
| 196 |
Cash reduction related to loss of control of Acasti (note 13) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities |
| 197 |
Cash flows from (used in) investing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
| 198 |
Cash flows used in financing activities: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract |
| 199 |
Payment of debt issuance transaction costs |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PaymentsForDebtIssueCosts |
| 200 |
Repayment of loans and borrowings (note 20 (c)) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities |
| 201 |
Increase in long-term debt, net of finance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities |
| 202 |
Interest paid |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestPaidClassifiedAsFinancingActivities |
| 203 |
Penalty on debt reimbursement (note 20 (c)) |
Concept (Monetary) |
For Period |
Credit |
nept:PenaltyOnDebtReimbursement |
| 204 |
Settlement of derivative swap agreements (note 20 (c)) |
Concept (Monetary) |
For Period |
Credit |
nept:SettlementOfDerivativeSwapAgreements |
| 205 |
Issuance of shares costs (note 12 (b)) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PaymentsForShareIssueCosts |
| 206 |
Proceeds from exercise of options (note 12 (d)) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromExerciseOfOptions |
| 207 |
Proceeds from Acasti warrants |
Concept (Monetary) |
For Period |
Debit |
nept:ProceedsFromIssuingWarrants |
| 208 |
Net proceeds from Acasti public offering (note 13 (ii)) and private placement |
Concept (Monetary) |
For Period |
Debit |
nept:NetProceedsFromPublicOfferingAndPrivatePlacement |
| 209 |
Cash flows from (used in) financing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
| 210 |
Foreign exchange gain (loss) on cash and cash equivalents held in foreign currencies |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| 211 |
Net increase in cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalents |
| 212 |
Cash and cash equivalents as at April 1, 2017 and March 1, 2016 |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 213 |
Cash and cash equivalents as at March 31, 2018 and 2017 |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 214 |
Cash and cash equivalents is comprised of: |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
| 215 |
Cash |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Cash |
| 216 |
Cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashEquivalents |
| 217 |
100070 - Disclosure - Reporting Entity |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureReportingEntity |
| 218 |
Implied Table |
Table |
* |
* |
implied:Table |
| 219 |
Disclosure Of Reporting Entity [Abstract] |
Abstract |
|
|
nept:DisclosureOfReportingEntityAbstract |
| 220 |
Reporting entity |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfReportingEntityExplanatory |
| 221 |
100080 - Disclosure - Basis of Preparation |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureBasisOfPreparation |
| 222 |
Implied Table |
Table |
* |
* |
implied:Table |
| 223 |
Disclosure Of Basis Of Preparation [Abstract] |
Abstract |
|
|
nept:DisclosureOfBasisOfPreparationAbstract |
| 224 |
Basis of preparation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory |
| 225 |
100090 - Disclosure - Significant Accounting Policies |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSignificantAccountingPolicies |
| 226 |
Implied Table |
Table |
* |
* |
implied:Table |
| 227 |
Disclosure Of Significant Accounting Policies [Abstract] |
Abstract |
|
|
nept:DisclosureOfSignificantAccountingPoliciesAbstract |
| 228 |
Significant accounting policies |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
| 229 |
100100 - Disclosure - Sale of Assets |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSaleOfAssets |
| 230 |
Implied Table |
Table |
* |
* |
implied:Table |
| 231 |
Disclosure Of Sale Of Assets [Abstract] |
Abstract |
|
|
nept:DisclosureOfSaleOfAssetsAbstract |
| 232 |
Sale of assets |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfSaleOfAssetsExplanatory |
| 233 |
100110 - Disclosure - Trade and Other Receivables |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureTradeAndOtherReceivables |
| 234 |
Implied Table |
Table |
* |
* |
implied:Table |
| 235 |
Trade And Other Current Receivables [Abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentReceivablesAbstract |
| 236 |
Trade and other receivables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory |
| 237 |
100120 - Disclosure - Inventories |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureInventories |
| 238 |
Implied Table |
Table |
* |
* |
implied:Table |
| 239 |
Classes Of Inventories [Abstract] |
Abstract |
|
|
ifrs-full:ClassesOfInventoriesAbstract |
| 240 |
Inventories |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInventoriesExplanatory |
| 241 |
100130 - Disclosure - Property, Plant and Equipment |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosurePropertyPlantAndEquipment |
| 242 |
Implied Table |
Table |
* |
* |
implied:Table |
| 243 |
Disclosure Of Property Plant And Equipment [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentAbstract |
| 244 |
Property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory |
| 245 |
100140 - Disclosure - Intangible Assets and Goodwill |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIntangibleAssetsAndGoodwill |
| 246 |
Implied Table |
Table |
* |
* |
implied:Table |
| 247 |
Disclosure Of Intangible Assets And Goodwill [Abstract] |
Abstract |
|
|
nept:DisclosureOfIntangibleAssetsAndGoodwillAbstract |
| 248 |
Intangible assets and goodwill |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory |
| 249 |
100150 - Disclosure - Trade and Other Payables |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureTradeAndOtherPayables |
| 250 |
Implied Table |
Table |
* |
* |
implied:Table |
| 251 |
Trade And Other Current Payables [Abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentPayablesAbstract |
| 252 |
Trade and other payables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory |
| 253 |
100160 - Disclosure - Loans and Borrowings |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureLoansAndBorrowings |
| 254 |
Implied Table |
Table |
* |
* |
implied:Table |
| 255 |
Borrowings [Abstract] |
Abstract |
|
|
ifrs-full:BorrowingsAbstract |
| 256 |
Loans and borrowings |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBorrowingsExplanatory |
| 257 |
100170 - Disclosure - Long-term Payable |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureLongTermPayable |
| 258 |
Implied Table |
Table |
* |
* |
implied:Table |
| 259 |
Long Term Payable [Abstract] |
Abstract |
|
|
nept:LongTermPayableAbstract |
| 260 |
Long-term payable |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfLongTermPayableExplanatory |
| 261 |
100180 - Disclosure - Capital and other components of equity |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquity |
| 262 |
Implied Table |
Table |
* |
* |
implied:Table |
| 263 |
Disclosure Of Share Capital Reserves And Other Equity Interest [Abstract] |
Abstract |
|
|
nept:DisclosureOfShareCapitalReservesAndOtherEquityInterestAbstract |
| 264 |
Capital and other components of equity |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory |
| 265 |
100190 - Disclosure - Non-controlling Interests ("NCI") |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureNonControllingInterestsNCI |
| 266 |
Implied Table |
Table |
* |
* |
implied:Table |
| 267 |
Disclosure Of Significant Investments In Subsidiaries [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesAbstract |
| 268 |
Non-controlling interests ("NCI") |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNoncontrollingInterestsExplanatory |
| 269 |
100200 - Disclosure - Other Income |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOtherIncome |
| 270 |
Implied Table |
Table |
* |
* |
implied:Table |
| 271 |
Disclosure Of Other Income [Abstract] |
Abstract |
|
|
nept:DisclosureOfOtherIncomeAbstract |
| 272 |
Other income |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfOtherIncomeExplanatory |
| 273 |
100210 - Disclosure - Personnel Expenses |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosurePersonnelExpenses |
| 274 |
Implied Table |
Table |
* |
* |
implied:Table |
| 275 |
Personnel Expenses [Abstract] |
Abstract |
|
|
nept:PersonnelExpensesAbstract |
| 276 |
Personnel expenses |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory |
| 277 |
100220 - Disclosure - Finance Costs |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinanceCosts |
| 278 |
Implied Table |
Table |
* |
* |
implied:Table |
| 279 |
Disclosure Of Finance Income And Costs [Abstract] |
Abstract |
|
|
nept:DisclosureOfFinanceIncomeAndCostsAbstract |
| 280 |
Finance Costs |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory |
| 281 |
100230 - Disclosure - Share-based Payments |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPayments |
| 282 |
Implied Table |
Table |
* |
* |
implied:Table |
| 283 |
Disclosure Share Based Payment Arrangement [Abstract] |
Abstract |
|
|
nept:DisclosureShareBasedPaymentArrangementAbstract |
| 284 |
Share-based payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory |
| 285 |
100240 - Disclosure - Income Taxes |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxes |
| 286 |
Implied Table |
Table |
* |
* |
implied:Table |
| 287 |
Disclosure Of Income Tax [Abstract] |
Abstract |
|
|
nept:DisclosureOfIncomeTaxAbstract |
| 288 |
Income Taxes |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
| 289 |
100250 - Disclosure - Income per share |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomePerShare |
| 290 |
Implied Table |
Table |
* |
* |
implied:Table |
| 291 |
Reconciliation Of Number Of Shares Outstanding [Abstract] |
Abstract |
|
|
ifrs-full:ReconciliationOfNumberOfSharesOutstandingAbstract |
| 292 |
Income per share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEarningsPerShareExplanatory |
| 293 |
100260 - Disclosure - Supplemental Cash Flow Disclosure |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSupplementalCashFlowDisclosure |
| 294 |
Implied Table |
Table |
* |
* |
implied:Table |
| 295 |
Disclosure Of Supplementary Cash Flow Information [Abstract] |
Abstract |
|
|
nept:DisclosureOfSupplementaryCashFlowInformationAbstract |
| 296 |
Supplemental Cash Flow Disclosure |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCashFlowStatementExplanatory |
| 297 |
100270 - Disclosure - Financial Instruments |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstruments |
| 298 |
Implied Table |
Table |
* |
* |
implied:Table |
| 299 |
Disclosure Of Financial Instruments [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsAbstract |
| 300 |
Financial instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsExplanatory |
| 301 |
100280 - Disclosure - Operating Leases |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOperatingLeases |
| 302 |
Implied Table |
Table |
* |
* |
implied:Table |
| 303 |
Operating Leases [Abstract] |
Abstract |
|
|
nept:OperatingLeasesAbstract |
| 304 |
Operating leases |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfLeasesExplanatory |
| 305 |
100290 - Disclosure - Commitments and contingencies |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCommitmentsAndContingencies |
| 306 |
Implied Table |
Table |
* |
* |
implied:Table |
| 307 |
Disclosure Of Commitments And Contingencies [Abstract] |
Abstract |
|
|
nept:DisclosureOfCommitmentsAndContingenciesAbstract |
| 308 |
Commitments and contingencies |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCommitmentsAndContingentLiabilitiesExplanatory |
| 309 |
100300 - Disclosure - Capital Management |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalManagement |
| 310 |
Implied Table |
Table |
* |
* |
implied:Table |
| 311 |
Capital Management [Abstract] |
Abstract |
|
|
nept:CapitalManagementAbstract |
| 312 |
Capital Management |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfCapitalManagementExplanatory |
| 313 |
100310 - Disclosure - Operating segments |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOperatingSegments |
| 314 |
Implied Table |
Table |
* |
* |
implied:Table |
| 315 |
Disclosure Of Operating Segments [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfOperatingSegmentsAbstract |
| 316 |
Operating Segments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory |
| 317 |
100320 - Disclosure - Related Parties |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureRelatedParties |
| 318 |
Implied Table |
Table |
* |
* |
implied:Table |
| 319 |
Disclosure Of Transactions Between Related Parties [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 320 |
Related parties |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
| 321 |
100330 - Disclosure - Significant Accounting Policies (Policies) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSignificantAccountingPoliciesPolicies |
| 322 |
Implied Table |
Table |
* |
* |
implied:Table |
| 323 |
Disclosure Of Significant Accounting Policies [Abstract] |
Abstract |
|
|
nept:DisclosureOfSignificantAccountingPoliciesAbstract |
| 324 |
Basis of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBasisOfConsolidationExplanatory |
| 325 |
Financial instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory |
| 326 |
Inventories |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories |
| 327 |
Property, plant and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
| 328 |
Intangible assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsAndGoodwillExplanatory |
| 329 |
Impairment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory |
| 330 |
Provisions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory |
| 331 |
Revenue |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue |
| 332 |
Government grants |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForGovernmentGrants |
| 333 |
Lease payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory |
| 334 |
Foreign currency |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory |
| 335 |
Employee benefits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory |
| 336 |
Finance income and finance costs |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinanceIncomeAndCostsExplanatory |
| 337 |
Income tax |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIncomeTaxExplanatory |
| 338 |
Earnings per share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory |
| 339 |
Segment reporting |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory |
| 340 |
New standard and interpretation adopted during the year |
Concept (Text Block (HTML)) |
For Period |
|
nept:DescriptionOfAccountingPolicyForRecentlyAdoptedAndNewAccountingPronouncementsExplanatory |
| 341 |
New standards and interpretations not yet adopted |
Concept (Text Block (HTML)) |
For Period |
|
nept:DescriptionOfAccountingPolicyForNewStandardsAndInterpretationsNotYetAdoptedExplanatory |
| 342 |
100340 - Disclosure - Significant Accounting Policies (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSignificantAccountingPoliciesTables |
| 343 |
Implied Table |
Table |
* |
* |
implied:Table |
| 344 |
Disclosure Of Significant Accounting Policies [Abstract] |
Abstract |
|
|
nept:DisclosureOfSignificantAccountingPoliciesAbstract |
| 345 |
Schedule of Estimated Useful Lives |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfPropertyPlantAndEquipmentEstimatedUsefulLifeExplanatory |
| 346 |
100350 - Disclosure - Sale of Assets (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSaleOfAssetsTables |
| 347 |
Implied Table |
Table |
* |
* |
implied:Table |
| 348 |
Disclosure Of Sale Of Assets [Abstract] |
Abstract |
|
|
nept:DisclosureOfSaleOfAssetsAbstract |
| 349 |
Schedule of Reconciliation of Net Gain on Sale of Assets |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfReconciliationOfNetGainOnSaleOfAssetsExplanatory |
| 350 |
100360 - Disclosure - Trade and Other Receivables (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureTradeAndOtherReceivablesTables |
| 351 |
Implied Table |
Table |
* |
* |
implied:Table |
| 352 |
Trade And Other Current Receivables [Abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentReceivablesAbstract |
| 353 |
Summary of Trade and Other Receivables |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDetailedInformationAboutTradeAndOtherReceivablesExplanatory |
| 354 |
100370 - Disclosure - Inventories (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureInventoriesTables |
| 355 |
Implied Table |
Table |
* |
* |
implied:Table |
| 356 |
Classes Of Inventories [Abstract] |
Abstract |
|
|
ifrs-full:ClassesOfInventoriesAbstract |
| 357 |
Schedule of Inventories |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDetailedInformationAboutInventoriesExplanatory |
| 358 |
100380 - Disclosure - Property, Plant and Equipment (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosurePropertyPlantAndEquipmentTables |
| 359 |
Implied Table |
Table |
* |
* |
implied:Table |
| 360 |
Disclosure Of Property Plant And Equipment [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentAbstract |
| 361 |
Summary of Property Plant and Equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory |
| 362 |
Summary of Depreciation Expense of Property Plant and Equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDepreciationAndAmortisationExpenseExplanatory |
| 363 |
100390 - Disclosure - Intangible Assets and Goodwill (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillTables |
| 364 |
Implied Table |
Table |
* |
* |
implied:Table |
| 365 |
Disclosure Of Intangible Assets And Goodwill [Abstract] |
Abstract |
|
|
nept:DisclosureOfIntangibleAssetsAndGoodwillAbstract |
| 366 |
Schedule of Reconciliation of Changes in Intangible Assets and Goodwill |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillExplanatory |
| 367 |
100400 - Disclosure - Trade and Other Payables (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureTradeAndOtherPayablesTables |
| 368 |
Implied Table |
Table |
* |
* |
implied:Table |
| 369 |
Trade And Other Current Payables [Abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentPayablesAbstract |
| 370 |
Summary of Trade and Other Payables |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDetailedInformationAboutTradeAndOtherPayablesExplanatory |
| 371 |
100410 - Disclosure - Loans and Borrowings (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureLoansAndBorrowingsTables |
| 372 |
Implied Table |
Table |
* |
* |
implied:Table |
| 373 |
Borrowings [Abstract] |
Abstract |
|
|
ifrs-full:BorrowingsAbstract |
| 374 |
Summary of Contractual Terms of Corporation's Loans and Borrowings |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory |
| 375 |
100420 - Disclosure - Capital and Other Components of Equity (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquityTables |
| 376 |
Implied Table |
Table |
* |
* |
implied:Table |
| 377 |
Default Root [Abstract] |
Abstract |
|
|
nept:DefaultRootAbstract |
| 378 |
Summary of Warrants |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfNumberOfWarrantsOutstandingAndExercisableExplanatory |
| 379 |
100430 - Disclosure - Non-controlling Interests ("NCI") (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureNonControllingInterestsNCITables |
| 380 |
Implied Table |
Table |
* |
* |
implied:Table |
| 381 |
Disclosure Of Significant Investments In Subsidiaries [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesAbstract |
| 382 |
Summary of reconciliation of gain on loss of control in subsidiary |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInvestmentEntitiesExplanatory |
| 383 |
100440 - Disclosure - Personnel Expense (Table) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosurePersonnelExpenseTable |
| 384 |
Implied Table |
Table |
* |
* |
implied:Table |
| 385 |
Personnel Expenses [Abstract] |
Abstract |
|
|
nept:PersonnelExpensesAbstract |
| 386 |
Disclosure of Employee Related Expense Explanatory |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfEmployeeRelatedExpenseExplanatory |
| 387 |
100450 - Disclosure - Finance Costs (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinanceCostsTables |
| 388 |
Implied Table |
Table |
* |
* |
implied:Table |
| 389 |
Disclosure Of Finance Income And Costs [Abstract] |
Abstract |
|
|
nept:DisclosureOfFinanceIncomeAndCostsAbstract |
| 390 |
Summary of Finance Costs |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceCostExplanatory |
| 391 |
100460 - Disclosure - Share-based Payments (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsTables |
| 392 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 393 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 394 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 395 |
Stock Option Plan |
Member |
|
|
nept:StockOptionPlanMember |
| 396 |
Performance Options |
Member |
|
|
nept:PerformanceOptionsMember |
| 397 |
Deferred Share Units |
Member |
|
|
nept:DeferredShareUnitsMember |
| 398 |
Warrants |
Member |
|
|
nept:WarrantsMember |
| 399 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 400 |
Schedule of Number and Weighted Average Exercise Price |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory |
| 401 |
Schedule of Number and Contractual Life |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory |
| 402 |
Summary of Assumptions Used to Determine Fair Value of Options Granted |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodExplanatory |
| 403 |
Schedule of Number and Weighted Average Exercise Price |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory |
| 404 |
100470 - Disclosure - Income Taxes (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxesTables |
| 405 |
Implied Table |
Table |
* |
* |
implied:Table |
| 406 |
Disclosure Of Income Tax [Abstract] |
Abstract |
|
|
nept:DisclosureOfIncomeTaxAbstract |
| 407 |
Schedule of Current Income Taxes Expense |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDetailedInformationAboutCurrentIncomeTaxesExpenseExplanatory |
| 408 |
Schedule of Deferred Taxes Expense (Income) |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDetailedInformationAboutDeferredTaxesExpenseIncomeExplanatory |
| 409 |
Schedule of Reconciliation of Effective Tax Rate |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDetailedInformationAboutReconciliationOfEffectiveTaxRateExplanatory |
| 410 |
Schedule of Recognized Deferred Tax Assets and Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDetailedInformationAboutRecognizedDeferredTaxAssetsAndLiabilitiesExplanatory |
| 411 |
Schedule of Tax Losses Carried Forward |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDetailedInformationAboutTaxLossesCarriedForwardExplanatory |
| 412 |
Schedule of Unused Tax Credits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsExplanatory |
| 413 |
100480 - Disclosure - Income per share (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomePerShareTables |
| 414 |
Implied Table |
Table |
* |
* |
implied:Table |
| 415 |
Reconciliation Of Number Of Shares Outstanding [Abstract] |
Abstract |
|
|
ifrs-full:ReconciliationOfNumberOfSharesOutstandingAbstract |
| 416 |
Summary of Reconciliation of Number of Shares Outstanding |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfReconciliationOfNumberOfSharesOutstandingExplanatory |
| 417 |
100490 - Disclosure - Supplemental Cash Flow Disclosure (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSupplementalCashFlowDisclosureTables |
| 418 |
Implied Table |
Table |
* |
* |
implied:Table |
| 419 |
Disclosure Of Supplementary Cash Flow Information [Abstract] |
Abstract |
|
|
nept:DisclosureOfSupplementaryCashFlowInformationAbstract |
| 420 |
Summary of Supplemental Cash Flow Disclosure |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAdditionalInformationAboutUnderstandingFinancialPositionsAndLiquidityOfEntityExplanatory |
| 421 |
Summary of Reconciliation of Liabilities to Cash Flows from Financing Activities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesExplanatory |
| 422 |
100500 - Disclosure - Financial Instruments (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsTables |
| 423 |
Disclosure Of Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 424 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
| 425 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
| 426 |
Foreign Exchange Rate Risk |
Member |
|
|
nept:ForeignExchangeRateRiskMember |
| 427 |
Interest rate risk [member] |
Member |
|
|
ifrs-full:InterestRateRiskMember |
| 428 |
Disclosure Of Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 429 |
Schedule of Reconciliation of Changes in Fair Value Measurement of Financial Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfReconciliationOfChangesInFairValueMeasurementOfFinancialLiabilitiesExplanatory |
| 430 |
Schedule of Derivative Swap Agreements |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfDerivativeSwapAgreementsExplanatory |
| 431 |
Schedule of Maturity Analysis Associated with Interest Rate Swap Agreement Used to Manage Interest Risk Associated with Long-Term Debt |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfMaturityAnalysisAssociatedWithInterestRateSwapAgreementUsedToManageInterestRiskAssociatedWithLongTermDebtExplanatory |
| 432 |
Schedule of Aging of Trade Receivable Balances and Allowance for Doubtful Accounts |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfAgingOfTradeReceivableBalancesAndAllowanceForDoubtfulAccountsExplanatory |
| 433 |
Schedule of Movement of Trade Receivable Allowance for Doubtful Accounts |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfMovementOfTradeReceivableAllowanceForDoubtfulAccountsExplanatory |
| 434 |
Schedule of Effect of Changes in Foreign Exchange Currency |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfEffectOfChangesInForeignExchangeCurrencyExplanatory |
| 435 |
Summary of Corporation’s Exposure to Interest Rate Risk |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfCorporationsExposureToInterestRateRiskExplanatory |
| 436 |
Schedule of Contractual Maturities of Financial Liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:MaturityAnalysisForDerivativeFinancialLiabilities |
| 437 |
100510 - Disclosure - Capital Management (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalManagementTables |
| 438 |
Implied Table |
Table |
* |
* |
implied:Table |
| 439 |
Capital Management [Abstract] |
Abstract |
|
|
nept:CapitalManagementAbstract |
| 440 |
Summary of Cash Equivalents and Restricted Short-term Investments |
Concept (Text Block (HTML)) |
For Period |
|
nept:DisclosureOfCashEquivalentsAndRestrictedShortTermInvestmentsExplanatory |
| 441 |
100520 - Disclosure - Operating segments (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOperatingSegmentsTables |
| 442 |
Implied Table |
Table |
* |
* |
implied:Table |
| 443 |
Disclosure Of Operating Segments [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfOperatingSegmentsAbstract |
| 444 |
Summary of Information About Reportable Segments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOperatingSegmentsExplanatory |
| 445 |
Summary of Revenue from Sales Based on Destination |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGeographicalAreasExplanatory |
| 446 |
100530 - Disclosure - Related Parties (Tables) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureRelatedPartiesTables |
| 447 |
Implied Table |
Table |
* |
* |
implied:Table |
| 448 |
Disclosure Of Transactions Between Related Parties [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 449 |
Summary of Key Management Personnel Compensation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory |
| 450 |
100540 - Disclosure - Significant Accounting Policies - Schedule of Estimated Useful Lives (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLivesDetails |
| 451 |
Disclosure Of Significant Accounting Policies [Table] |
Table |
* |
* |
nept:DisclosureOfSignificantAccountingPoliciesTable |
| 452 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 453 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 454 |
Building and building components |
Member |
|
|
ifrs-full:BuildingsMember |
| 455 |
Laboratory, R&D and plant equipment |
Member |
|
|
ifrs-full:OtherPropertyPlantAndEquipmentMember |
| 456 |
Furniture and office equipment |
Member |
|
|
ifrs-full:OfficeEquipmentMember |
| 457 |
Computer equipment |
Member |
|
|
ifrs-full:ComputerEquipmentMember |
| 458 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 459 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 460 |
Bottom of range |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 461 |
Top of range |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 462 |
Disclosure Of Significant Accounting Policies [Line Items] |
LineItems |
|
|
nept:DisclosureOfSignificantAccountingPoliciesLineItems |
| 463 |
Method |
Concept (Text/String) |
For Period |
|
ifrs-full:DepreciationMethodPropertyPlantAndEquipment |
| 464 |
Period/Rate |
Concept (Text/String) |
For Period |
|
ifrs-full:UsefulLivesOrDepreciationRatesPropertyPlantAndEquipment |
| 465 |
100550 - Disclosure - Significant Accounting Policies - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails |
| 466 |
Disclosure Of Significant Accounting Policies [Table] |
Table |
* |
* |
nept:DisclosureOfSignificantAccountingPoliciesTable |
| 467 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
| 468 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
| 469 |
Acasti |
Member |
|
|
nept:AcastiPharmaIncMember |
| 470 |
Disclosure Of Significant Accounting Policies [Line Items] |
LineItems |
|
|
nept:DisclosureOfSignificantAccountingPoliciesLineItems |
| 471 |
Fair value of financial asset reclassified from accumulated other comprehensive income to deficit on initial application of IFRS 9 |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FairValueOfFinancialAssetsReclassifiedOutOfFairValueThroughProfitOrLossAndIntoFairValueThroughOtherComprehensiveIncomeInitialApplicationOfIFRS9 |
| 472 |
100560 - Disclosure - Sale of Assets - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSaleOfAssetsAdditionalInformationDetails |
| 473 |
Disclosure Of Sale Of Assets [Table] |
Table |
* |
* |
nept:DisclosureOfSaleOfAssetsTable |
| 474 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 475 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 476 |
Aker BioMarine Antarctic AS |
Member |
|
|
nept:AkerBioMarineAntarcticASMember |
| 477 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 478 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 479 |
Krill Oil |
Member |
|
|
nept:KrillOilMember |
| 480 |
Disclosure Of Sale Of Assets [Line Items] |
LineItems |
|
|
nept:DisclosureOfSaleOfAssetsLineItems |
| 481 |
Acquisition for cash consideration |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets |
| 482 |
Debt reimbursement |
Concept (Monetary) |
As Of |
Credit |
nept:DebtInstrumentReimbursedAmount |
| 483 |
Penalty on debt reimbursement |
Concept (Monetary) |
For Period |
Credit |
nept:PenaltyOnDebtReimbursement |
| 484 |
Additional debt reimbursement |
Concept (Monetary) |
For Period |
Credit |
nept:AdditionalRepaymentsOfDebt |
| 485 |
Manufacturing and distribution sale |
Concept (Monetary) |
For Period |
Debit |
nept:ManufacturingAndDistributionSaleAmount |
| 486 |
Impairment loss on inventories |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories |
| 487 |
Gross margin, excluding impairment loss on inventories |
Concept (Monetary) |
For Period |
Debit |
nept:GrossMarginExcludingImpairmentLossOnInventories |
| 488 |
Revaluation of useful life |
Concept (Text/String) |
For Period |
|
nept:RevaluationOfUsefulLife |
| 489 |
Impairment of plant and related equipment |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossPropertyPlantAndEquipment |
| 490 |
100570 - Disclosure - Sale of Assets - Schedule of Reconciliation of Net Gain on Sale of Assets (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSaleOfAssetsScheduleOfReconciliationOfNetGainOnSaleOfAssetsDetails |
| 491 |
Disclosure Of Sale Of Assets [Table] |
Table |
* |
* |
nept:DisclosureOfSaleOfAssetsTable |
| 492 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 493 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 494 |
Krill Oil |
Member |
|
|
nept:KrillOilMember |
| 495 |
Disclosure Of Sale Of Assets [Line Items] |
LineItems |
|
|
nept:DisclosureOfSaleOfAssetsLineItems |
| 496 |
Acquisition for cash consideration |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets |
| 497 |
Inventory sold |
Concept (Monetary) |
For Period |
Debit |
nept:InventorySold |
| 498 |
Net intangible assets sold |
Concept (Monetary) |
For Period |
Debit |
nept:NetIntangibleAssetsSold |
| 499 |
Write-off of assets, severance costs, transaction costs and costs for activities relating to exiting the bulk krill oil business |
Concept (Monetary) |
For Period |
Debit |
nept:WriteOffOfAssetsSeveranceCostsTransactionCostsAndCostsForExitingActivities |
| 500 |
Net gain on sale of assets as presented in the consolidated statement of earnings |
Concept (Monetary) |
For Period |
Credit |
nept:NetGainOnSaleOfAssets |
| 501 |
Impairment loss in inventories - presented in cost of sales |
Concept (Monetary) |
For Period |
Debit |
nept:AdjustmentsForImpairmentLossReversalOfImpairmentLossRelatedToSaleOfAssetsRecognisedInProfitOrLossInventories |
| 502 |
Penalty on reimbursement, loss on financing fees and reversal of accretion from non-interest bearing debt reimbursed – presented in finance costs |
Concept (Monetary) |
For Period |
Debit |
nept:FinanceCostsDueToPenaltyOnReimbursementLossOnFinancingFeesAndReversalOfAccretionFromNonInterestBearingDebtReimbursement |
| 503 |
Total impact of the transaction on the net income before tax |
Concept (Monetary) |
For Period |
Credit |
nept:NetIncomeBeforeTax |
| 504 |
100580 - Disclosure - Sale of Assets - Schedule of Reconciliation of Net Gain on Sale of Assets (Parenthetical) (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSaleOfAssetsScheduleOfReconciliationOfNetGainOnSaleOfAssetsParentheticalDetails |
| 505 |
Implied Table |
Table |
* |
* |
implied:Table |
| 506 |
Disclosure Of Sale Of Assets [Abstract] |
Abstract |
|
|
nept:DisclosureOfSaleOfAssetsAbstract |
| 507 |
Non-cash write-off assets |
Concept (Monetary) |
For Period |
Debit |
nept:NonCashWriteOffAssets |
| 508 |
Employee severance cost |
Concept (Monetary) |
For Period |
Debit |
nept:EmployeeSeveranceCost |
| 509 |
Transaction costs |
Concept (Monetary) |
For Period |
Debit |
nept:TransactionCosts |
| 510 |
100590 - Disclosure - Trade and Other Receivables - Summary of Trade and Other Receivables (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureTradeAndOtherReceivablesSummaryOfTradeAndOtherReceivablesDetails |
| 511 |
Implied Table |
Table |
* |
* |
implied:Table |
| 512 |
Trade And Other Current Receivables [Abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentReceivablesAbstract |
| 513 |
Trade receivables |
Concept (Monetary) |
As Of |
Debit |
nept:CurrentTradeReceivablesNetOfAllowance |
| 514 |
Sales taxes receivable |
Concept (Monetary) |
As Of |
Debit |
nept:SalesTaxesReceivableCurrent |
| 515 |
Accrued and other receivables |
Concept (Monetary) |
As Of |
Debit |
nept:AccruedAndOtherReceivablesCurrent |
| 516 |
Grants receivables |
Concept (Monetary) |
As Of |
Debit |
nept:GrantsReceivablesCurrent |
| 517 |
Trade and other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherCurrentReceivables |
| 518 |
100600 - Disclosure - Inventories - Schedule of Inventories (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureInventoriesScheduleOfInventoriesDetails |
| 519 |
Implied Table |
Table |
* |
* |
implied:Table |
| 520 |
Classes Of Inventories [Abstract] |
Abstract |
|
|
ifrs-full:ClassesOfInventoriesAbstract |
| 521 |
Raw materials |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:RawMaterials |
| 522 |
Work in progress |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:WorkInProgress |
| 523 |
Finished goods |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinishedGoods |
| 524 |
Supplies and spare parts |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherInventories |
| 525 |
Inventories |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
| 526 |
100610 - Disclosure - Inventories - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureInventoriesAdditionalInformationDetails |
| 527 |
Disclosure Of Inventories [Table] |
Table |
* |
* |
nept:DisclosureOfInventoriesTable |
| 528 |
Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis] |
Axis |
|
|
ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis |
| 529 |
Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [member] |
Member |
|
|
ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember |
| 530 |
Aker BioMarine (“Aker”) |
Member |
|
|
nept:AkerBioMarineMember |
| 531 |
Disclosure Of Inventories [Line Items] |
LineItems |
|
|
nept:DisclosureOfInventoriesLineItems |
| 532 |
Cost of sales |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
| 533 |
Inventory cost |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfInventoriesRecognisedAsExpenseDuringPeriod |
| 534 |
Other inventory costs |
Concept (Monetary) |
For Period |
Debit |
nept:OtherInventoryCosts |
| 535 |
Impairment loss on inventories |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossInventories |
| 536 |
Inventory sold |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 537 |
100620 - Disclosure - Property, Plant and Equipment - Summary of Property Plant and Equipment (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosurePropertyPlantAndEquipmentSummaryOfPropertyPlantAndEquipmentDetails |
| 538 |
Disclosure Of Property Plant And Equipment [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
| 539 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
| 540 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 541 |
Land |
Member |
|
|
ifrs-full:LandMember |
| 542 |
Building and Building Components |
Member |
|
|
nept:BuildingAndBuildingComponentsMember |
| 543 |
Laboratory, R&D and Plant Equipment |
Member |
|
|
nept:LaboratoryResearchAndDevelopmentAndPlantEquipmentMember |
| 544 |
Furniture and Office Equipment |
Member |
|
|
nept:FurnitureAndOfficeEquipmentMember |
| 545 |
Computer equipment |
Member |
|
|
ifrs-full:ComputerEquipmentMember |
| 546 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 547 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 548 |
Gross Carrying Amount |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 549 |
Accumulated Depreciation |
Member |
|
|
ifrs-full:AccumulatedDepreciationAndAmortisationMember |
| 550 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 551 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 552 |
Acasti |
Member |
|
|
nept:AcastiPharmaIncMember |
| 553 |
Disclosure Of Property Plant And Equipment [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
| 554 |
Beginning Balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 555 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment |
| 556 |
Disposals |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsPropertyPlantAndEquipment |
| 557 |
Loss of control of Acasti |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesRecognisedWhenControlInSubsidiaryIsLost |
| 558 |
Depreciation for the period |
Concept (Monetary) |
For Period |
|
ifrs-full:DepreciationPropertyPlantAndEquipment |
| 559 |
Ending Balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
| 560 |
100630 - Disclosure - Property, Plant and Equipment - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosurePropertyPlantAndEquipmentAdditionalInformationDetails |
| 561 |
Implied Table |
Table |
* |
* |
implied:Table |
| 562 |
Disclosure Of Property Plant And Equipment [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentAbstract |
| 563 |
Property, plant and equipment, not yet in service |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipmentTemporarilyIdle |
| 564 |
100640 - Disclosure - Property, Plant and Equipment - Summary of Depreciation Expense of Property Plant and Equipment (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosurePropertyPlantAndEquipmentSummaryOfDepreciationExpenseOfPropertyPlantAndEquipmentDetails |
| 565 |
Disclosure Of Property Plant And Equipment [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
| 566 |
Income Statement Location1 |
Axis |
|
|
nept:IncomeStatementLocation1Axis |
| 567 |
Income Statement Location1 Member |
Member |
|
|
nept:IncomeStatementLocation1Member |
| 568 |
Cost of sales |
Member |
|
|
nept:CostOfSales1Member |
| 569 |
Research and development expenses |
Member |
|
|
nept:ResearchAndDevelopmentExpensesMember |
| 570 |
Selling, general and administrative expenses |
Member |
|
|
nept:SellingGeneralAndAdministrativeExpenseMember |
| 571 |
Disclosure Of Property Plant And Equipment [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
| 572 |
Depreciation expense |
Concept (Monetary) |
For Period |
|
ifrs-full:DepreciationPropertyPlantAndEquipment |
| 573 |
100650 - Disclosure - Intangible Assets and Goodwill - Schedule of Reconciliation of Changes in Intangible Assets and Goodwill - (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillScheduleOfReconciliationOfChangesInIntangibleAssetsAndGoodwillDetails |
| 574 |
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable |
| 575 |
Classes of intangible assets and goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis |
| 576 |
Intangible assets and goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsAndGoodwillMember |
| 577 |
Non-Compete Agreements |
Member |
|
|
nept:NonCompeteAgreementMember |
| 578 |
Customer Relationships |
Member |
|
|
ifrs-full:CustomerrelatedIntangibleAssetsMember |
| 579 |
Patents |
Member |
|
|
ifrs-full:CopyrightsPatentsAndOtherIndustrialPropertyRightsServiceAndOperatingRightsMember |
| 580 |
License Agreement |
Member |
|
|
ifrs-full:LicencesMember |
| 581 |
Trademarks |
Member |
|
|
nept:TrademarkMember |
| 582 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
| 583 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
| 584 |
Gross Carrying Amount |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
| 585 |
Accumulated Depreciation |
Member |
|
|
ifrs-full:AccumulatedDepreciationAndAmortisationMember |
| 586 |
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillLineItems |
| 587 |
Beginning Balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsAndGoodwill |
| 588 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill |
| 589 |
Sale to Aker BioMarine (note 4) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsAndGoodwill |
| 590 |
Amortization |
Concept (Monetary) |
For Period |
|
ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill |
| 591 |
Ending Balance |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsAndGoodwill |
| 592 |
100660 - Disclosure - Intangible Assets and Goodwill - Additional Information - (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIntangibleAssetsAndGoodwillAdditionalInformationDetails |
| 593 |
Disclosure Of Intangible Assets [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
| 594 |
Income Statement Location1 |
Axis |
|
|
nept:IncomeStatementLocation1Axis |
| 595 |
Income Statement Location1 Member |
Member |
|
|
nept:IncomeStatementLocation1Member |
| 596 |
Selling, general and administrative expenses |
Member |
|
|
nept:SellingGeneralAndAdministrativeExpenseMember |
| 597 |
Disclosure Of Intangible Assets [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
| 598 |
Amortization expense |
Concept (Monetary) |
For Period |
|
ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill |
| 599 |
Discount rate on discounted cash flow |
Concept (Percent) |
For Period |
|
nept:DiscountRateOnDiscountedCashFlow |
| 600 |
Terminal growth rate |
Concept (Percent) |
For Period |
|
nept:TerminalGrowthRate |
| 601 |
100670 - Disclosure - Trade and Other Payables - Summary of Trade and Other Payables (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureTradeAndOtherPayablesSummaryOfTradeAndOtherPayablesDetails |
| 602 |
Implied Table |
Table |
* |
* |
implied:Table |
| 603 |
Trade And Other Current Payables [Abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherCurrentPayablesAbstract |
| 604 |
Trade payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers |
| 605 |
Accrued liabilities and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccrualsClassifiedAsCurrent |
| 606 |
Employee salaries and benefits payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ShorttermEmployeeBenefitsAccruals |
| 607 |
Trade and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
| 608 |
100680 - Disclosure - Loans and Borrowings - Summary of Contractual Terms of Corporation's Loans and Borrowings (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureLoansAndBorrowingsSummaryOfContractualTermsOfCorporationSLoansAndBorrowingsDetails |
| 609 |
Disclosure Of Detailed Information About Borrowings [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 610 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 611 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 612 |
2.5% Secured Loan |
Member |
|
|
nept:TwoPointFivePercentageSecuredLoanMember |
| 613 |
Balance of Purchase Price |
Member |
|
|
nept:BalanceOfPurchasePriceMember |
| 614 |
Authorized bank line of credit |
Member |
|
|
nept:AuthorizedBankLineOfCreditMember |
| 615 |
Finance Lease Liabilities |
Member |
|
|
nept:FinanceLeaseLiabilitiesMember |
| 616 |
8% Secured Loan |
Member |
|
|
nept:EightPercentageSecuredLoanMember |
| 617 |
12% Secured Loan |
Member |
|
|
nept:TwelvePercentageSecuredLoanMember |
| 618 |
Refundable Contribution |
Member |
|
|
nept:RefundableContributionMember |
| 619 |
Disclosure Of Detailed Information About Borrowings [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 620 |
Loans |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LoansReceived |
| 621 |
Total loans and borrowings |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 622 |
Finance lease liabilities, interest rate from 6.25% to 7.13%, payable in monthly instalments of $2,345, maturing in November 2018 and March 2019. |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinanceLeaseLiabilities |
| 623 |
Loans and borrowings (note 10) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentPortionOfLongtermBorrowings |
| 624 |
Loans and borrowings (note 10) |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LongtermBorrowings |
| 625 |
100690 - Disclosure - Loans and Borrowings - Summary of Contractual Terms of Corporation's Loans and Borrowings (Parenthetical) (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureLoansAndBorrowingsSummaryOfContractualTermsOfCorporationSLoansAndBorrowingsParentheticalDetails |
| 626 |
Disclosure Of Detailed Information About Borrowings [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsTable |
| 627 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 628 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 629 |
2.5% Secured Loan |
Member |
|
|
nept:TwoPointFivePercentageSecuredLoanMember |
| 630 |
Balance of Purchase Price Amount Bearing 5% Interest |
Member |
|
|
nept:BalanceOfPurchasePriceAmountBearingFivePercentageInterestMember |
| 631 |
Balance of Purchase Price Amount Bearing 7% Interest |
Member |
|
|
nept:BalanceOfPurchasePriceAmountBearingSevenPercentageInterestMember |
| 632 |
Authorized bank line of credit |
Member |
|
|
nept:AuthorizedBankLineOfCreditMember |
| 633 |
Finance Lease Liabilities |
Member |
|
|
nept:FinanceLeaseLiabilitiesMember |
| 634 |
8% Secured Loan |
Member |
|
|
nept:EightPercentageSecuredLoanMember |
| 635 |
12% Secured Loan |
Member |
|
|
nept:TwelvePercentageSecuredLoanMember |
| 636 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 637 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 638 |
Bottom of range |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 639 |
Top of range |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 640 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 641 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 642 |
December 2018 |
Member |
|
|
nept:DecemberTwoThousandEighteenMember |
| 643 |
March 2016 to Septmber 2018 |
Member |
|
|
nept:MarchTwoThousandSixteenToSeptemberTwoThousandEighteenMember |
| 644 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
| 645 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
| 646 |
Prime Rate |
Member |
|
|
nept:PrimeRatesMember |
| 647 |
Disclosure Of Detailed Information About Borrowings [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsLineItems |
| 648 |
Loans and borrowings, adjustment to interest rate basis |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsAdjustmentToInterestRateBasis |
| 649 |
Loans and borrowings, reimbursable monthly principal payments |
Concept (Monetary) |
For Period |
Debit |
nept:BorrowingsReimbursableMonthlyPrincipalPayments |
| 650 |
Loan final payment |
Concept (Monetary) |
For Period |
Debit |
nept:LoanFinalPayment |
| 651 |
Short-term investments pledged for loan |
Concept (Monetary) |
As Of |
Debit |
nept:ShortTermInvestmentsPledgedForLoan |
| 652 |
Loans, transaction costs |
Concept (Monetary) |
For Period |
|
ifrs-full:BorrowingCostsIncurred |
| 653 |
Loans and borrowings, interest rate |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsInterestRate |
| 654 |
Borrowings, reimbursable quarterly principal payments |
Concept (Monetary) |
For Period |
Debit |
nept:BorrowingsReimbursableQuarterlyPrincipalPayments |
| 655 |
Loans and borrowings, principal amount |
Concept (Monetary) |
As Of |
|
ifrs-full:NotionalAmount |
| 656 |
Borrowings expiration date |
Concept (Date/Time) |
For Period |
|
nept:BorrowingsExpirationDate |
| 657 |
Borrowings, payable in monthly instalments |
Concept (Monetary) |
As Of |
Credit |
nept:BorrowingsMonthlyInstalmentsPayable |
| 658 |
Borrowings maturity |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsMaturity |
| 659 |
100700 - Disclosure - Loans and Borrowings - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureLoansAndBorrowingsAdditionalInformationDetails |
| 660 |
Implied Table |
Table |
* |
* |
implied:Table |
| 661 |
Disclosure Of Detailed Information About Borrowings [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsAbstract |
| 662 |
Interest recognized |
Concept (Monetary) |
For Period |
|
ifrs-full:InterestCostsIncurred |
| 663 |
100710 - Disclosure - Long-term-Payable - Additional Information (Detail) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureLongTermPayableAdditionalInformationDetail |
| 664 |
Implied Table |
Table |
* |
* |
implied:Table |
| 665 |
Noncurrent Payables [Abstract] |
Abstract |
|
|
ifrs-full:NoncurrentPayablesAbstract |
| 666 |
Intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 667 |
Intangible assets fair value |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetFairValueUsedAsDeemedCost |
| 668 |
Royalty fee payable |
Concept (Monetary) |
As Of |
Credit |
nept:RoyaltyFeePayableCurrentAndNoncurrent |
| 669 |
Description of payment terms |
Concept (Text/String) |
For Period |
|
nept:DescriptionOfSignificantPaymentTermsWithCounterparty |
| 670 |
Royalty agreement term |
Concept (xbrli:durationItemType) |
For Period |
|
nept:CounterpartyAgreementTerm |
| 671 |
Short term payable |
Concept (Monetary) |
As Of |
|
nept:CurrentPayablesToTradeSuppliers |
| 672 |
Long term payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentPayablesToTradeSuppliers |
| 673 |
100720 - Disclosure - Capital and Other Components of Equity - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquityAdditionalInformationDetails |
| 674 |
Disclosure Of Classes Of Share Capital [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 675 |
Classes of ordinary shares [axis] |
Axis |
|
|
ifrs-full:ClassesOfOrdinarySharesAxis |
| 676 |
Ordinary shares [member] |
Member |
|
|
ifrs-full:OrdinarySharesMember |
| 677 |
Preference shares [member] |
Member |
|
|
ifrs-full:PreferenceSharesMember |
| 678 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 679 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 680 |
Share Option Exercise |
Member |
|
|
nept:ShareOptionExerciseMember |
| 681 |
Disclosure Of Classes Of Share Capital [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 682 |
Percentage of dividend issued on paid up capital |
Concept (Percent) |
For Period |
|
nept:PercentageOfDividendIssuedOnPaidUpCapital |
| 683 |
Number of shares issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
| 684 |
Number of shares outstanding |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesOutstanding |
| 685 |
Liability settled in shares, shares |
Concept (Shares) |
For Period |
|
nept:LiabilitySettledInSharesShares |
| 686 |
Share Issue Price Per Share |
Concept (Share) |
As Of |
|
nept:ShareIssuePricePerShare |
| 687 |
Share issued on settlement of liability, value |
Concept (Monetary) |
For Period |
Credit |
nept:SharesIssuedForSettlementOfLiabilityValue |
| 688 |
Share issue costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
| 689 |
DSU released, shares |
Concept (Shares) |
For Period |
|
nept:IncreaseDecreaseThroughDeferredShareUnitsReleasedShares |
| 690 |
Number of options excercised |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement |
| 691 |
Proceeds from exercise of options |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromExerciseOfOptions |
| 692 |
100730 - Disclosure - Capital and Other Components of Equity - Summary of Warrants (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsDetails |
| 693 |
Implied Table |
Table |
* |
* |
implied:Table |
| 694 |
Disclosure Of Share Capital Reserves And Other Equity Interest [Abstract] |
Abstract |
|
|
nept:DisclosureOfShareCapitalReservesAndOtherEquityInterestAbstract |
| 695 |
Number of warrants outstanding and exercisable |
Concept (Shares) |
As Of |
|
nept:NumberOfWarrantsOutstandingAndExercisable |
| 696 |
Warrants amount |
Concept (Monetary) |
As Of |
Credit |
nept:Warrants |
| 697 |
100740 - Disclosure - Capital and Other Components of Equity - Summary of Warrants (Parenthetical) (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalAndOtherComponentsOfEquitySummaryOfWarrantsParentheticalDetails |
| 698 |
Disclosure Of Classes Of Share Capital [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
| 699 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 700 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 701 |
Warrants I Q Financing |
Member |
|
|
nept:WarrantsIQFinancingMember |
| 702 |
Disclosure Of Classes Of Share Capital [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
| 703 |
Warrants exercise price |
Concept (Share) |
For Period |
|
invest:InvestmentWarrantsExercisePrice |
| 704 |
Warrants expiring date |
Concept (Date) |
For Period |
|
invest:InvestmentWarrantsExpirationDate |
| 705 |
100750 - Disclosure - Non-controlling Interests ("NCI") - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureNonControllingInterestsNCIAdditionalInformationDetails |
| 706 |
Disclosure Of Significant Investments In Subsidiaries [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesTable |
| 707 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
| 708 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
| 709 |
Acasti |
Member |
|
|
nept:AcastiPharmaIncMember |
| 710 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
| 711 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
| 712 |
Non-controlling Interest |
Member |
|
|
ifrs-full:NoncontrollingInterestsMember |
| 713 |
Classes of share capital [axis] |
Axis |
|
|
ifrs-full:ClassesOfShareCapitalAxis |
| 714 |
Share capital [member] |
Member |
|
|
ifrs-full:ClassesOfShareCapitalMember |
| 715 |
Public Offering |
Member |
|
|
nept:PublicOfferingMember |
| 716 |
Disclosure Of Significant Investments In Subsidiaries [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesLineItems |
| 717 |
Percentage of subsidiary owned |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInSubsidiary |
| 718 |
Proportion of ownership interests held by non-controlling interests on a fully diluted basis |
Concept (Percent) |
For Period |
|
nept:ProportionOfOwnershipInterestsHeldByNonControllingInterestsOnFullyDilutedBasis |
| 719 |
Proportion of voting right held by non-controlling interests on a fully diluted basis |
Concept (Percent) |
For Period |
|
nept:ProportionOfVotingRightHeldByNonControllingInterestsOnFullyDilutedBasis |
| 720 |
Number of shares owned in subsidiary |
Concept (Shares) |
As Of |
|
ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates |
| 721 |
Fair value of investment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssetsAtFairValue |
| 722 |
Fair value of investment, per share |
Concept (Share) |
As Of |
|
nept:FinancialAssetsAtFairValuePerShare |
| 723 |
Gain on loss of control of subsidiary |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainLossOnCessationOfConsolidationOfSubsidiariesDueToChangeOfInvestmentEntityStatus |
| 724 |
Impact of expiry of Acasti options and call-options |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseThroughExpiryOfSubsidiariesOptionsAndCallOptions |
| 725 |
Impact on non-controlling interest resulting from exercise of broker warrants |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseInNonControllingInterestResultingFromExerciseOfBrokerWarrants |
| 726 |
Impact on non-controlling interest resulting from financing fees related to past financing |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseInNonControllingInterestResultingFromFinancingFeesRelatedToPastFinancing |
| 727 |
Impact on non-controlling interest resulting from issue of shares to settle convertible debentures interest |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseInNonControllingInterestResultingFromIssueOfSharesToSettleConvertibleDebenturesInterest |
| 728 |
Impact of expiry of Acasti options and call-options |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseThroughExpiryOfOptionsAndCallOptions |
| 729 |
Number of shares issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
| 730 |
Share issued price |
Concept (Share) |
As Of |
|
nept:SharesIssuedPrice |
| 731 |
Gross proceeds from issuing units |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
| 732 |
Transaction costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 733 |
Principal amount of unsecured debentures and contingent warrant issued |
Concept (Monetary) |
For Period |
Debit |
nept:PrincipalAmountOfUnsecuredDebenturesAndContingentWarrantIssued |
| 734 |
Number of contingent warrants to acquire common shares |
Concept (Shares) |
For Period |
|
nept:NumberOfContingentWarrantsToAcquireCommonShares |
| 735 |
The change in equity resulting from the public offering |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseThroughPublicOffering |
| 736 |
Impact of private placement |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfConvertibleInstruments |
| 737 |
100760 - Disclosure - Non-controlling Interests ("NCI") - Summary of reconciliation of gain on loss of control in subsidiary (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureNonControllingInterestsNCISummaryOfReconciliationOfGainOnLossOfControlInSubsidiaryDetails |
| 738 |
Disclosure Of Significant Investments In Subsidiaries [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesTable |
| 739 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
| 740 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
| 741 |
Acasti |
Member |
|
|
nept:AcastiPharmaIncMember |
| 742 |
Disclosure Of Significant Investments In Subsidiaries [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesLineItems |
| 743 |
Investment in Acasti at fair value |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FairValueOfSubsidiariesThatCeaseToBeConsolidatedAsOfDateOfChangeOfInvestmentEntityStatus |
| 744 |
Non-controlling interest |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncontrollingInterests |
| 745 |
Acasti's assets before deconsolidation |
Concept (Monetary) |
As Of |
Debit |
nept:AssetsBeforeDeconsolidationOfSubsidiary |
| 746 |
Acasti's liabilities before deconsolidation |
Concept (Monetary) |
As Of |
Credit |
nept:LiabilitiesBeforeDeconsolidationOfSubsidiary |
| 747 |
Gain on loss on control of Acasti |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainLossOnCessationOfConsolidationOfSubsidiariesDueToChangeOfInvestmentEntityStatus |
| 748 |
100770 - Disclosure - Other Income - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOtherIncomeAdditionalInformationDetails |
| 749 |
Disclosure Of Other Income [Table] |
Table |
* |
* |
nept:DisclosureOfOtherIncomeTable |
| 750 |
Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [axis] |
Axis |
|
|
ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationAxis |
| 751 |
Transactions recognised separately from acquisition of assets and assumption of liabilities in business combination [member] |
Member |
|
|
ifrs-full:TransactionsRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombinationMember |
| 752 |
Neptune and Aker BioMarine (“Aker”) |
Member |
|
|
nept:NeptuneAndAkerBioMarineMember |
| 753 |
Neptune and Enzymotec Ltd (“Enzymotec”) |
Member |
|
|
nept:NeptuneAndEnzymotecLtdMember |
| 754 |
Product Or Service |
Axis |
|
|
us-gaap:ProductOrServiceAxis |
| 755 |
Products And Services |
Member |
|
|
us-gaap:ProductsAndServicesDomain |
| 756 |
krill oil-related patent portfolio |
Member |
|
|
nept:KrillOilPatentMember |
| 757 |
Disclosure Of Other Income [Line Items] |
LineItems |
|
|
nept:DisclosureOfOtherIncomeLineItems |
| 758 |
Royalty payment |
Concept (Monetary) |
For Period |
Debit |
nept:RoyaltyPayment |
| 759 |
Royalty settlement income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromRoyalties |
| 760 |
Intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
| 761 |
100780 - Disclosure - Personnel Expenses - Schedule of Personnel Expenses (Detail) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosurePersonnelExpensesScheduleOfPersonnelExpensesDetail |
| 762 |
Implied Table |
Table |
* |
* |
implied:Table |
| 763 |
Personnel Expenses [Abstract] |
Abstract |
|
|
nept:PersonnelExpensesAbstract |
| 764 |
Salaries and other short-term employee benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShorttermEmployeeBenefitsExpense |
| 765 |
Severance |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TerminationBenefitsExpense |
| 766 |
Share-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
| 767 |
Total personnel expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EmployeeBenefitsExpense |
| 768 |
100790 - Disclosure - Finance Costs - Summary of Finance Costs (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinanceCostsSummaryOfFinanceCostsDetails |
| 769 |
Implied Table |
Table |
* |
* |
implied:Table |
| 770 |
Disclosure Of Finance Income And Costs [Abstract] |
Abstract |
|
|
nept:DisclosureOfFinanceIncomeAndCostsAbstract |
| 771 |
Interest charges and other finance costs |
Concept (Monetary) |
For Period |
Debit |
nept:InterestChargesAndOtherFinanceCosts |
| 772 |
Interest expense on unsecured convertible debentures |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestExpenseOnDebtInstrumentsIssued |
| 773 |
Penalty on reimbursment, loss on financing and discounted fees on debt reimbursment (note 4) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:InterestIncomeReimbursementRights |
| 774 |
Foreign exchange loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:NetForeignExchangeLoss |
| 775 |
Finance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 776 |
100800 - Disclosure - Share-based Payments - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsAdditionalInformationDetails |
| 777 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 778 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 779 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 780 |
Stock Option Plan |
Member |
|
|
nept:StockOptionPlanMember |
| 781 |
Performance Options |
Member |
|
|
nept:PerformanceOptionsMember |
| 782 |
Deferred Share Units |
Member |
|
|
nept:DeferredShareUnitsMember |
| 783 |
Acasti Stock Option Plan |
Member |
|
|
nept:AcastiStockOptionPlanMember |
| 784 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 785 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 786 |
Top of range |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 787 |
Bottom of range |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 788 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 789 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 790 |
Non Employees |
Member |
|
|
nept:NonEmployeesMember |
| 791 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 792 |
Options term |
Concept (Decimal) |
For Period |
|
ifrs-full:DescriptionOfOptionLifeShareOptionsGranted |
| 793 |
Vesting period |
Concept (Decimal) |
For Period |
|
nept:OptionsVestingPeriod |
| 794 |
Percentage of common shares issued and outstanding |
Concept (Percent) |
For Period |
|
nept:PercentageOfCommonSharesIssuedAndOutstandingAtTimeOfAnyGrant |
| 795 |
Percent of stock common shares issuable to single holder |
Concept (Percent) |
For Period |
|
nept:PercentageOfCommonShareIssuableToSingleHolder |
| 796 |
Maximum percent of option issuable |
Concept (Percent) |
For Period |
|
nept:MaximumPercentOfOptionIssuable |
| 797 |
Number of options, Restriction |
Concept (Decimal) |
For Period |
|
nept:NumberOfShareOptionsRestrictedInShareBasedPaymentArrangement |
| 798 |
Weighted average fair value of options granted to employees |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted |
| 799 |
Number of options granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 800 |
Stock-based compensation recognized |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
| 801 |
Weighted average exercise price, Granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 802 |
Expiration date |
Concept (Date) |
For Period |
|
invest:InvestmentOptionsExpirationDate |
| 803 |
Vesting period |
Concept (xbrli:durationItemType) |
For Period |
|
nept:SharebasedPaymentArrangementVestingPeriod |
| 804 |
Description of vesting requirements for share-based payment arrangement |
Concept (Text/String) |
For Period |
|
ifrs-full:DescriptionOfVestingRequirementsForSharebasedPaymentArrangement |
| 805 |
Number of share options outstanding in share-based payment arrangement |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 806 |
Number of other equity instruments exercised or vested in share-based payment arrangement |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement |
| 807 |
Number of share fully vested |
Concept (Decimal) |
For Period |
|
nept:SharesFullyVested |
| 808 |
Weighted average fair value |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement |
| 809 |
Stock-based compensation recognized |
Concept (Monetary) |
For Period |
Debit |
nept:ShareBasedCompensationExpense |
| 810 |
100810 - Disclosure - Share-based Payments - Schedule of Number and Weighted Average Exercise Price of Stock Options (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsScheduleOfNumberAndWeightedAverageExercisePriceOfStockOptionsDetails |
| 811 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 812 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 813 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 814 |
Stock Option Plan |
Member |
|
|
nept:StockOptionPlanMember |
| 815 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 816 |
Weighted average exercise price, Beginning balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 817 |
Weighted average exercise price, Granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 818 |
Weighted average exercise price, Exercised |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement |
| 819 |
Weighted average exercise price, Forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 820 |
Weighted average exercise price, Expired |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement |
| 821 |
Weighted average exercise price, Ending balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 822 |
Weighted average exercise price, Exercisable |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 823 |
Number of options outstanding, Beginning balance |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 824 |
Number of options, Granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 825 |
Number of options, Exercised |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement |
| 826 |
Number of options, Forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 827 |
Number of options, Expired |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement |
| 828 |
Number of options outstanding, Ending balance |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 829 |
Number of options, Exercisable |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 830 |
100820 - Disclosure - Share-based Payments - Schedule of Number and Weighted Average Exercise Price of Stock Options (Parenthetical) (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsScheduleOfNumberAndWeightedAverageExercisePriceOfStockOptionsParentheticalDetails |
| 831 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 832 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 833 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 834 |
Stock Option Plan |
Member |
|
|
nept:StockOptionPlanMember |
| 835 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 836 |
Number of options, Granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
| 837 |
Number of options, Restriction |
Concept (Decimal) |
For Period |
|
nept:NumberOfShareOptionsRestrictedInShareBasedPaymentArrangement |
| 838 |
100830 - Disclosure - Share-based Payments - Schedule of Number and Contractual Life of Options (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsScheduleOfNumberAndContractualLifeOfOptionsDetails |
| 839 |
Disclosure Of Number And Weighted Average Remaining Contractual Life Of Outstanding Share Options [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable |
| 840 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 841 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 842 |
Stock Option Plan |
Member |
|
|
nept:StockOptionPlanMember |
| 843 |
Ranges of exercise prices for outstanding share options [axis] |
Axis |
|
|
ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis |
| 844 |
Ranges of exercise prices for outstanding share options [member] |
Member |
|
|
ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsMember |
| 845 |
$1.24 - $1.82 |
Member |
|
|
nept:ExercisePriceRangeOneMember |
| 846 |
$1.83 - $1.91 |
Member |
|
|
nept:ExercisePriceRangeTwoMember |
| 847 |
$1.92 - $2.05 |
Member |
|
|
nept:ExercisePriceRangeThreeMember |
| 848 |
$2.06 - $2.15 |
Member |
|
|
nept:ExercisePriceRangeFourMember |
| 849 |
$2.16 |
Member |
|
|
nept:ExercisePriceRangeFiveMember |
| 850 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 851 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 852 |
Bottom of range |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 853 |
Top of range |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 854 |
Disclosure Of Number And Weighted Average Remaining Contractual Life Of Outstanding Share Options [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems |
| 855 |
Exercise price |
Concept (Monetary) |
As Of |
|
ifrs-full:ExercisePriceOfOutstandingShareOptions |
| 856 |
Options outstanding, Weighted remaining contractual life outstanding |
Concept (Decimal) |
As Of |
|
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions |
| 857 |
Options outstanding, Number of options outstanding |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 858 |
Exercisable options, Weighted number of options exercisable |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 859 |
Weighted average exercise price, Exercisable |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 860 |
100840 - Disclosure - Share-based Payments - Summary of Assumptions Used to Determine Fair Value of Options Granted (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsSummaryOfAssumptionsUsedToDetermineFairValueOfOptionsGrantedDetails |
| 861 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 862 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 863 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 864 |
Stock Option Plan |
Member |
|
|
nept:StockOptionPlanMember |
| 865 |
Valuation techniques used in fair value measurement [axis] |
Axis |
|
|
ifrs-full:ValuationTechniquesUsedInFairValueMeasurementAxis |
| 866 |
Valuation techniques [member] |
Member |
|
|
ifrs-full:ValuationTechniquesMember |
| 867 |
Black Scholes Option Pricing Model |
Member |
|
|
nept:BlackScholesOptionPricingModelMember |
| 868 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 869 |
Exercise price |
Concept (Monetary) |
For Period |
|
ifrs-full:ExercisePriceShareOptionsGranted |
| 870 |
Share price |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageSharePriceShareOptionsGranted |
| 871 |
Dividend |
Concept (Monetary) |
For Period |
|
ifrs-full:ExpectedDividendShareOptionsGranted |
| 872 |
Risk-free interest |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted |
| 873 |
Estimated life (years) |
Concept (Decimal) |
For Period |
|
ifrs-full:DescriptionOfOptionLifeShareOptionsGranted |
| 874 |
Expected volatility |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted |
| 875 |
100850 - Disclosure - Share-based Payments - Schedule of Number and Weighted Average Exercise Price of Performance Options (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsScheduleOfNumberAndWeightedAverageExercisePriceOfPerformanceOptionsDetails |
| 876 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 877 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 878 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 879 |
Performance Options |
Member |
|
|
nept:PerformanceOptionsMember |
| 880 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 881 |
Number of options outstanding, Beginning balance |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 882 |
Number of options, Forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 883 |
Number of options outstanding, Ending balance |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 884 |
Number of options, Exercisable |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 885 |
Weighted average exercise price, Beginning balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 886 |
Weighted average exercise price, Forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement |
| 887 |
Weighted average exercise price, Ending balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
| 888 |
Weighted average exercise price, Exercisable |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 889 |
100860 - Disclosure - Share-based Payments - Schedule of Number and Contractual Life of Performance Options (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsScheduleOfNumberAndContractualLifeOfPerformanceOptionsDetails |
| 890 |
Disclosure Of Number And Weighted Average Remaining Contractual Life Of Outstanding Share Options [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable |
| 891 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 892 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 893 |
Performance Options |
Member |
|
|
nept:PerformanceOptionsMember |
| 894 |
Disclosure Of Number And Weighted Average Remaining Contractual Life Of Outstanding Share Options [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems |
| 895 |
Exercise price |
Concept (Monetary) |
As Of |
|
ifrs-full:ExercisePriceOfOutstandingShareOptions |
| 896 |
Options outstanding, Weighted remaining contractual life outstanding |
Concept (Decimal) |
As Of |
|
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions |
| 897 |
Options outstanding, Number of options outstanding |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
| 898 |
Exercisable options, Weighted number of options exercisable |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 899 |
Weighted average exercise price, Exercisable |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
| 900 |
100870 - Disclosure - Share-based Payments - Schedule of Number and Weighted Average Exercise Price of Deferred Share Units (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsScheduleOfNumberAndWeightedAverageExercisePriceOfDeferredShareUnitsDetails |
| 901 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 902 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
| 903 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
| 904 |
Deferred Share Units |
Member |
|
|
nept:DeferredShareUnitsMember |
| 905 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 906 |
Beginning balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 907 |
Granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement |
| 908 |
Released through the issuance of common shares |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement |
| 909 |
Ending balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 910 |
Exercisable options |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement |
| 911 |
Beginning balance |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 912 |
Granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted |
| 913 |
Released through the issuance of common shares |
Concept (Shares) |
For Period |
|
nept:IncreaseDecreaseThroughDeferredShareUnitsReleasedShares |
| 914 |
Ending balance |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 915 |
Exercisable options |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement |
| 916 |
100880 - Disclosure - Share-based Payments - Schedule of Number and Weighted Average Exercise Price of Warrants (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureShareBasedPaymentsScheduleOfNumberAndWeightedAverageExercisePriceOfWarrantsDetails |
| 917 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
| 918 |
Statement Class Of Stock |
Axis |
|
|
us-gaap:StatementClassOfStockAxis |
| 919 |
Class Of Stock |
Member |
|
|
us-gaap:ClassOfStockDomain |
| 920 |
Warrants |
Member |
|
|
nept:WarrantsMember |
| 921 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
| 922 |
Beginning balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 923 |
Weighted average price, forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement |
| 924 |
Weighted average price, expired |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement |
| 925 |
Ending balance |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 926 |
Beginning balance |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 927 |
Number of warrants, forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement |
| 928 |
Number of warrants, expired |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfOtherEquityInstrumentsExpiredInSharebasedPaymentArrangement |
| 929 |
Ending balance |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement |
| 930 |
100890 - Disclosure - Income Taxes - Schedule of Current Income Taxes Expense (Recovery) (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxesScheduleOfCurrentIncomeTaxesExpenseRecoveryDetails |
| 931 |
Implied Table |
Table |
* |
* |
implied:Table |
| 932 |
Disclosure Of Income Tax [Abstract] |
Abstract |
|
|
nept:DisclosureOfIncomeTaxAbstract |
| 933 |
Current |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CurrentTaxExpenseIncome |
| 934 |
Adjustment of prior year income taxes expense (recovery) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod |
| 935 |
Current income taxes expense (recovery) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods |
| 936 |
100900 - Disclosure - Income Taxes - Schedule of Deferred Taxes Expense (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxesExpenseDetails |
| 937 |
Implied Table |
Table |
* |
* |
implied:Table |
| 938 |
Disclosure Of Income Tax [Abstract] |
Abstract |
|
|
nept:DisclosureOfIncomeTaxAbstract |
| 939 |
Recognition of previously unrecognized deductible temporary differences and tax losses of prior periods |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDeferredTaxOfPriorPeriods |
| 940 |
Origination and reversal of temporary differences |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DeferredTaxExpenseIncomeRelatingToOriginationAndReversalOfTemporaryDifferences |
| 941 |
Change in unrecognized deductible temporary differences |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DeferredTaxExpenseIncomeRelatingToTaxRateChangesOrImpositionOfNewTaxes |
| 942 |
Deferred tax expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DeferredTaxExpenseIncome |
| 943 |
100910 - Disclosure - Income Taxes - Summary of Reconciliation of Effective Tax Rate (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxesSummaryOfReconciliationOfEffectiveTaxRateDetails |
| 944 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
| 945 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 946 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 947 |
Acasti |
Member |
|
|
nept:AcastiMember |
| 948 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
| 949 |
Income before income taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
| 950 |
Basic combined Canadian statutory income tax rate |
Concept (Percent) |
For Period |
|
ifrs-full:ApplicableTaxRate |
| 951 |
Income tax |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TaxExpenseIncomeAtApplicableTaxRate |
| 952 |
Increase (decrease) resulting from: |
Abstract |
|
|
nept:TaxEffectOfIncreaseDecreaseResultingFromAbstract |
| 953 |
Recognition of previously unrecognized deductible temporary differences and tax losses of prior periods |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDeferredTaxOfPriorPeriods |
| 954 |
Change in unrecognized deductible temporary differences |
Concept (Monetary) |
For Period |
Debit |
nept:TaxEffectOfChangeInUnrecognizedDeductibleTemporaryDifferences |
| 955 |
Gain on loss of control of Acasti |
Concept (Monetary) |
For Period |
Credit |
nept:GainOnLossOfControlOfSubsidiary |
| 956 |
Non taxable gain on sale of assets |
Concept (Monetary) |
For Period |
Debit |
nept:TaxEffectOnNonTaxableGainOnSaleOfAssets |
| 957 |
Non-deductible stock-based compensation |
Concept (Monetary) |
For Period |
Debit |
nept:TaxEffectOfNotDeductibleStockBasedCompensation |
| 958 |
Non-deductible change in fair value |
Concept (Monetary) |
For Period |
Debit |
nept:TaxEffectOfNonDeductibleChangeInFairValue |
| 959 |
Permanent differences and other |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome |
| 960 |
Change in statutory income tax rate |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:TaxEffectFromChangeInTaxRate |
| 961 |
Total tax expense (recovery) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 962 |
100920 - Disclosure - Income Taxes - Summary of Recognized Deferred Tax Assets and Liabilities (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxesSummaryOfRecognizedDeferredTaxAssetsAndLiabilitiesDetails |
| 963 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
| 964 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
| 965 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
| 966 |
Tax losses carried forward |
Member |
|
|
nept:TaxLossesCarriedForwardMember |
| 967 |
Research and development expenses |
Member |
|
|
nept:ResearchAndDevelopmentExpensesMember |
| 968 |
Intangible assets |
Member |
|
|
nept:IntangibleAssetsMember |
| 969 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
| 970 |
Tax credits receivable |
Member |
|
|
nept:TaxCreditsReceivableMember |
| 971 |
Prepaid royalty income |
Member |
|
|
nept:PrepaidRoyaltyIncomeMember |
| 972 |
Unsecured Convertible Debentures |
Member |
|
|
nept:UnsecuredConvertibleDebenturesMember |
| 973 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
| 974 |
Beginning balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilityAsset |
| 975 |
Recognized in equity |
Concept (Monetary) |
For Period |
|
ifrs-full:DeferredTaxRelatingToItemsChargedOrCreditedDirectlyToEquity |
| 976 |
Recognized in net income |
Concept (Monetary) |
For Period |
|
ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss |
| 977 |
Ending balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DeferredTaxLiabilityAsset |
| 978 |
100930 - Disclosure - Income Taxes - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails |
| 979 |
Disclosure Of Income Tax [Table] |
Table |
* |
* |
nept:DisclosureOfIncomeTaxTable |
| 980 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
| 981 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
| 982 |
Temporary Differences |
Member |
|
|
ifrs-full:TemporaryDifferenceMember |
| 983 |
Research and development expenses |
Member |
|
|
nept:ResearchAndDevelopmentExpensesMember |
| 984 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 985 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 986 |
Nutraceutical |
Member |
|
|
nept:NutraceuticalMember |
| 987 |
Disclosure Of Income Tax [Line Items] |
LineItems |
|
|
nept:DisclosureOfIncomeTaxLineItems |
| 988 |
Deferred tax asset recognized |
Concept (Monetary) |
For Period |
|
ifrs-full:DeferredTaxExpenseIncomeRecognisedInProfitOrLoss |
| 989 |
Tax credits receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTaxAssetsCurrent |
| 990 |
Tax credits recoverable recognized in the period |
Concept (Monetary) |
As Of |
Debit |
nept:TaxCreditsRecoverableRecognizedInThePeriod |
| 991 |
Derecognition of prior period tax credits recoverable |
Concept (Monetary) |
As Of |
Debit |
nept:DerecognitionOfPriorPeriodTaxCreditsRecoverable |
| 992 |
100940 - Disclosure - Income Taxes - Summary of Tax Losses Carried Forward (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxesSummaryOfTaxLossesCarriedForwardDetails |
| 993 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
| 994 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 995 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 996 |
Federal |
Member |
|
|
nept:FederalMember |
| 997 |
Provincial |
Member |
|
|
nept:ProvincialMember |
| 998 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 999 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 1000 |
2035 |
Member |
|
|
nept:TwoThousandAndThirtyFiveMember |
| 1001 |
2036 |
Member |
|
|
nept:TwoThousandAndThirtySixMember |
| 1002 |
2037 |
Member |
|
|
nept:TwoThousandAndThirtySevenMember |
| 1003 |
2038 |
Member |
|
|
nept:TwoThousandAndThirtyEightyMember |
| 1004 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
| 1005 |
Tax losses carried forward |
Abstract |
|
|
nept:TaxLossesCarriedForwardAbstract |
| 1006 |
Tax losses carried forward |
Concept (Monetary) |
As Of |
Debit |
nept:TaxLossesCarriedForward |
| 1007 |
Research and development expenses, without time limitation |
Concept (Monetary) |
As Of |
Debit |
nept:ResearchAndDevelopmentExpensesWithoutTimeLimitation |
| 1008 |
100950 - Disclosure - Income Taxes - Schedule of Future Federal Income Taxes Payable and Expire (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomeTaxesScheduleOfFutureFederalIncomeTaxesPayableAndExpireDetails |
| 1009 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable |
| 1010 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 1011 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 1012 |
Federal |
Member |
|
|
nept:FederalMember |
| 1013 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 1014 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 1015 |
Nutraceutical |
Member |
|
|
nept:NutraceuticalMember |
| 1016 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
| 1017 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
| 1018 |
Research and development expenses |
Member |
|
|
nept:ResearchAndDevelopmentExpensesMember |
| 1019 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 1020 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 1021 |
2022 |
Member |
|
|
nept:TwoThousandAndTwentyTwoMember |
| 1022 |
2023 |
Member |
|
|
nept:TwoThousandAndTwentyThreeMember |
| 1023 |
2024 |
Member |
|
|
nept:TwoThousandAndTwentyFourMember |
| 1024 |
2025 |
Member |
|
|
nept:TwoThousandAndTwentyFiveMember |
| 1025 |
2026 |
Member |
|
|
nept:TwoThousandAndTwentySixMember |
| 1026 |
2027 |
Member |
|
|
nept:TwoThousandAndTwentySevenMember |
| 1027 |
2028 |
Member |
|
|
nept:TwoThousandAndTwentyEightMember |
| 1028 |
2029 |
Member |
|
|
nept:TwoThousandAndTwentyNineMember |
| 1029 |
2030 |
Member |
|
|
nept:TwoThousandAndThirtyMember |
| 1030 |
2031 |
Member |
|
|
nept:TwoThousandAndThirtyOneMember |
| 1031 |
2032 |
Member |
|
|
nept:TwoThousandAndThirtyTwoMember |
| 1032 |
2033 |
Member |
|
|
nept:TwoThousandAndThirtyThreeMember |
| 1033 |
2034 |
Member |
|
|
nept:TwoThousandAndThirtyFourMember |
| 1034 |
2035 |
Member |
|
|
nept:TwoThousandAndThirtyFiveMember |
| 1035 |
2036 |
Member |
|
|
nept:TwoThousandAndThirtySixMember |
| 1036 |
2037 |
Member |
|
|
nept:TwoThousandAndThirtySevenMember |
| 1037 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems |
| 1038 |
Unused tax credits for which no deferred tax asset recognised |
Concept (Monetary) |
As Of |
|
ifrs-full:UnusedTaxCreditsForWhichNoDeferredTaxAssetRecognised |
| 1039 |
100960 - Disclosure - Income Per Share - Summary of Reconciliation of Number of Shares Outstanding (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureIncomePerShareSummaryOfReconciliationOfNumberOfSharesOutstandingDetails |
| 1040 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1041 |
Reconciliation Of Number Of Shares Outstanding [Abstract] |
Abstract |
|
|
ifrs-full:ReconciliationOfNumberOfSharesOutstandingAbstract |
| 1042 |
Weighted average number of common shares |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
| 1043 |
Dilutive effect of deferred share units |
Concept (Shares) |
For Period |
|
nept:DilutiveEffectOfDeferredShareUnits |
| 1044 |
Dilutive effect of stock options |
Concept (Shares) |
For Period |
|
ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares |
| 1045 |
Weighted average number of diluted shares |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
| 1046 |
Number of anti-dilutive stock options, warrants and deferred share units excluded from diluted earnings per share calculation |
Concept (Shares) |
For Period |
|
nept:EquityInstrumentsWithPotentialFutureDilutiveEffectNotIncludedInCalculationOfDilutedEarningsPerShare |
| 1047 |
100970 - Disclosure - Supplemental Cash Flow Disclosure - Summary of Supplemental Cash Flow Disclosure - Changes in Operating Assets and Liabilities (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSupplementalCashFlowDisclosureSummaryOfSupplementalCashFlowDisclosureChangesInOperatingAssetsAndLiabilitiesDetails |
| 1048 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1049 |
Disclosure Of Supplementary Cash Flow Information [Abstract] |
Abstract |
|
|
nept:DisclosureOfSupplementaryCashFlowInformationAbstract |
| 1050 |
Trade and other receivables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables |
| 1051 |
Tax credits receivable |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxesRefundClassifiedAsOperatingActivities |
| 1052 |
Prepaid expenses |
Concept (Monetary) |
For Period |
Credit |
nept:AdjustmentsForIncreaseDecreaseInPrepaidExpenses |
| 1053 |
Inventories |
Concept (Monetary) |
For Period |
Debit |
nept:AdjustmentsForIncreaseDecreaseInInventories |
| 1054 |
Trade and other payables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables |
| 1055 |
Deferred revenues |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInDeferredIncome |
| 1056 |
Changes in operating assets and liabilities |
Concept (Monetary) |
For Period |
Debit |
nept:AdjustmentsForIncreaseDecreaseInChangesInOperatingAssetsAndLiabilities |
| 1057 |
100980 - Disclosure - Supplemental Cash Flow Disclosure - Summary of Supplemental Cash Flow Disclosure - Non-cash Transactions (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSupplementalCashFlowDisclosureSummaryOfSupplementalCashFlowDisclosureNonCashTransactionsDetails |
| 1058 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1059 |
Disclosure Of Supplementary Cash Flow Information [Abstract] |
Abstract |
|
|
nept:DisclosureOfSupplementaryCashFlowInformationAbstract |
| 1060 |
Acquired property, plant and equipment included in trade and other payables |
Concept (Monetary) |
For Period |
Credit |
nept:NonCashTransactionsAcquiredPropertyPlantAndEquipmentIncludedInTradeAndOtherPayables |
| 1061 |
Intangible assets included in trade and other payables |
Concept (Monetary) |
For Period |
Credit |
nept:NonCashTransactionsIntangibleAssetsIncludedInTradeAndOtherPayables |
| 1062 |
Intangible assets included in trade and other receivables (note 14) |
Concept (Monetary) |
For Period |
Debit |
nept:NonCashTransactionsIntangibleAssetsIncludedInTradeAndOtherReceivables |
| 1063 |
Intangible assets included in long-term payable |
Concept (Monetary) |
For Period |
Credit |
nept:NonCashTransactionsIntangibleAssetsIncludedInLongTermPayable |
| 1064 |
Liability settlement in shares |
Concept (Monetary) |
For Period |
Credit |
nept:SharesIssuedForSettlementOfLiabilityValue |
| 1065 |
Acasti convertible debenture interest paid in shares of subsidiary |
Concept (Monetary) |
For Period |
Debit |
nept:NonCashTransactionsConvertibleDebentureInterestPaidInSharesOfSubsidiary |
| 1066 |
Reduction in goodwill on reduction of balance of purchase price |
Concept (Monetary) |
For Period |
Debit |
nept:NonCashTransactionsReductionInGoodwillOnReductionOfBalanceOfPurchasePrice |
| 1067 |
Acasti equity settled share-based payment included in equity and unsecured convertible debentures |
Concept (Monetary) |
For Period |
Credit |
nept:NonCashTransactionsEquitySettledShareBasedPaymentIncludedInEquityAndUnsecuredConvertibleDebentures |
| 1068 |
Acasti issuance of broker warrants included in net proceeds from Acasti public offering |
Concept (Monetary) |
For Period |
Credit |
nept:NonCashTransactionsIssuanceOfBrokerWarrantsIncludedInNetProceedsFromPublicOffering |
| 1069 |
Acasti public offering transactions costs included in trade and other payables |
Concept (Monetary) |
For Period |
Credit |
nept:NonCashTransactionsPublicOfferingTransactionsCostsIncludedInTradeAndOtherPayables |
| 1070 |
Acasti reduction in share issue costs from reduction in trade and other payables |
Concept (Monetary) |
For Period |
Credit |
nept:NonCashTransactionsReductionInShareIssuanceCostsFromReductionInTradeAndOtherPayables |
| 1071 |
Acasti private placement transactions costs included in trade and other payables |
Concept (Monetary) |
For Period |
Credit |
nept:NonCashTransactionsPrivatePlacementTransactionsCostsIncludedInTradeAndOtherPayables |
| 1072 |
100990 - Disclosure - Supplemental Cash Flow Disclosure - Summary of Reconciliation of Liabilities to Cash Flows from Financing Activities (Detail) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSupplementalCashFlowDisclosureSummaryOfReconciliationOfLiabilitiesToCashFlowsFromFinancingActivitiesDetail |
| 1073 |
Disclosure Of Supplementary Cash Flow Information [Table] |
Table |
* |
* |
nept:DisclosureOfSupplementaryCashFlowInformationTable |
| 1074 |
Types of financial liabilities [axis] |
Axis |
|
|
ifrs-full:TypesOfFinancialLiabilitiesAxis |
| 1075 |
Financial liabilities, type [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesTypeMember |
| 1076 |
Loan |
Member |
|
|
nept:LoanMember |
| 1077 |
Balance of Purchase Price |
Member |
|
|
nept:BalanceOfPurchasePriceMember |
| 1078 |
Bank Line of Credit |
Member |
|
|
nept:BankLineOfCreditMember |
| 1079 |
Finance Lease Liabilities |
Member |
|
|
nept:FinanceLeaseLiabilitiesMember |
| 1080 |
Loan IQ |
Member |
|
|
nept:LoanIQMember |
| 1081 |
Loan in GBP |
Member |
|
|
nept:LoanInGBPMember |
| 1082 |
Refundable Contribution |
Member |
|
|
nept:RefundableContributionMember |
| 1083 |
Long-term Debt |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
| 1084 |
Interest Rate Swap Liability (Asset) Used for Hedging |
Member |
|
|
ifrs-full:AssetsHeldToHedgeLiabilitiesArisingFromFinancingActivitiesMember |
| 1085 |
Cross Currency Swap Liability |
Member |
|
|
nept:CrossCurrencySwapMember |
| 1086 |
Disclosure Of Supplementary Cash Flow Information [Line Items] |
LineItems |
|
|
nept:DisclosureOfSupplementaryCashFlowInformationLineItems |
| 1087 |
Beginning Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilitiesArisingFromFinancingActivities |
| 1088 |
Increase in long-term debt, net of finance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities |
| 1089 |
Repayments From Cash (used in) provided by financing activities |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities |
| 1090 |
Settlement of Cross Currency Swap From Cash (Used in) Provided by Financing Activities |
Concept (Monetary) |
For Period |
Credit |
nept:SettlementOfCrossCurrencySwapClassifiedAsFinancingActivities |
| 1091 |
Non-cash Changes Accretion of Interest |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseThroughChangeOfAccretionInterestLiabilitiesArisingFromFinancingActivities |
| 1092 |
Non-cash changes effect of foreign currency exchange rate changes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities |
| 1093 |
Non-cash changes financing and discounted fees |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities |
| 1094 |
Non-cash changes in fair value |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities |
| 1095 |
Ending Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilitiesArisingFromFinancingActivities |
| 1096 |
101000 - Disclosure - Supplemental Cash Flow Disclosure - Summary of Reconciliation of Liabilities to Cash Flows from Financing Activities (Parentheical) (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureSupplementalCashFlowDisclosureSummaryOfReconciliationOfLiabilitiesToCashFlowsFromFinancingActivitiesParentheicalDetails |
| 1097 |
Disclosure Of Supplementary Cash Flow Information [Table] |
Table |
* |
* |
nept:DisclosureOfSupplementaryCashFlowInformationTable |
| 1098 |
Types of financial liabilities [axis] |
Axis |
|
|
ifrs-full:TypesOfFinancialLiabilitiesAxis |
| 1099 |
Financial liabilities, type [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesTypeMember |
| 1100 |
Loan in GBP |
Member |
|
|
nept:LoanInGBPMember |
| 1101 |
Disclosure Of Supplementary Cash Flow Information [Line Items] |
LineItems |
|
|
nept:DisclosureOfSupplementaryCashFlowInformationLineItems |
| 1102 |
Penalty on debt reimbursement |
Concept (Monetary) |
For Period |
Credit |
nept:PenaltyOnDebtReimbursement |
| 1103 |
101010 - Disclosure - Financial Instruments - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsAdditionalInformationDetails |
| 1104 |
Disclosure Of Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 1105 |
Counterparties [axis] |
Axis |
|
|
ifrs-full:CounterpartiesAxis |
| 1106 |
Counterparties [member] |
Member |
|
|
ifrs-full:CounterpartiesMember |
| 1107 |
Blue Ocean Nutrascience Inc |
Member |
|
|
nept:BlueOceanNutrascienceIncMember |
| 1108 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
| 1109 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
| 1110 |
Cross Currency Swap |
Member |
|
|
nept:CrossCurrencySwapMember |
| 1111 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
| 1112 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
| 1113 |
Credit Risk |
Member |
|
|
ifrs-full:CreditRiskMember |
| 1114 |
Foreign Exchange Rate Risk |
Member |
|
|
nept:ForeignExchangeRateRiskMember |
| 1115 |
Interest rate risk [member] |
Member |
|
|
ifrs-full:InterestRateRiskMember |
| 1116 |
Major customers [axis] |
Axis |
|
|
ifrs-full:MajorCustomersAxis |
| 1117 |
Customers [member] |
Member |
|
|
ifrs-full:MajorCustomersMember |
| 1118 |
Customer One |
Member |
|
|
nept:CustomerOneMember |
| 1119 |
Customer Two |
Member |
|
|
nept:CustomerTwoMember |
| 1120 |
Customer Three |
Member |
|
|
nept:CustomerThreeMember |
| 1121 |
Customer Four |
Member |
|
|
nept:CustomerFourMember |
| 1122 |
Currency |
Axis |
|
|
us-gaap:CurrencyAxis |
| 1123 |
All Currencies |
Member |
|
|
currency:AllCurrenciesDomain |
| 1124 |
U S Dollars |
Member |
|
|
nept:USDollarsMember |
| 1125 |
Euro |
Member |
|
|
nept:EuroMember |
| 1126 |
Disclosure Of Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 1127 |
Proceeds on sale of assets (note 4) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets |
| 1128 |
Fair value of investment |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssetsAtFairValue |
| 1129 |
Fair value of investment, per share |
Concept (Share) |
As Of |
|
nept:FinancialAssetsAtFairValuePerShare |
| 1130 |
Losses on change In fair value of investment |
Concept (Monetary) |
For Period |
Debit |
nept:LossesOnChangeInFairValueOfInvestment |
| 1131 |
Change in fair value of derivative assets and liabilities |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnChangeInFairValueOfDerivatives |
| 1132 |
Non-cash changes in fair value |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughChangesInFairValuesLiabilitiesArisingFromFinancingActivities |
| 1133 |
Settlement of derivative swap agreements |
Concept (Monetary) |
For Period |
Credit |
nept:SettlementOfDerivativeSwapAgreements |
| 1134 |
Assumed foreign exchange rate |
Concept (Percent) |
For Period |
|
nept:AssumedForeignExchangeRate |
| 1135 |
Percentage of trade accounts |
Concept (Percent) |
For Period |
|
nept:PercentageOfTradeAccounts |
| 1136 |
Percentage of credit insurance on invoicing |
Concept (Percent) |
For Period |
|
nept:PercentageOfCreditInsuranceOnInvoicing |
| 1137 |
Allowance for doubtful accounts other receivables |
Concept (Monetary) |
As Of |
Credit |
nept:AllowanceForDoubtfulOtherReceivables |
| 1138 |
Percentage of revenues by geographical area |
Concept (Percent) |
For Period |
|
nept:PercentageOfRevenuesByGeographicalArea |
| 1139 |
Decrease in net profit |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseInNetIncomeOnEffectOfChangeInAssumedInterestRate |
| 1140 |
101020 - Disclosure - Financial Instruments - Schedule of Reconciliation of Changes in Fair Value Measurement of Financial Liabilities (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsScheduleOfReconciliationOfChangesInFairValueMeasurementOfFinancialLiabilitiesDetails |
| 1141 |
Disclosure Of Reconciliation Of Changes In Fair Value Measurement Liabilities [Table] |
Table |
* |
* |
nept:DisclosureOfReconciliationOfChangesInFairValueMeasurementLiabilitiesTable |
| 1142 |
Levels of fair value hierarchy [axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
| 1143 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
| 1144 |
Level 3 of Fair Value Hierarchy |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
| 1145 |
Classes of liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfLiabilitiesAxis |
| 1146 |
Liabilities [member] |
Member |
|
|
ifrs-full:LiabilitiesMember |
| 1147 |
Financial Liabilities |
Member |
|
|
nept:FinancialLiabilityMember |
| 1148 |
Disclosure Of Reconciliation Of Changes In Fair Value Measurement Liabilities [Line Items] |
LineItems |
|
|
nept:DisclosureOfReconciliationOfChangesInFairValueMeasurementLiabilitiesLineItems |
| 1149 |
Opening balance, financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
| 1150 |
Change in fair value (gain) loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseInFairValueMeasurementLiabilities |
| 1151 |
Loss of control of subsidiary |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesRecognisedWhenControlInSubsidiaryIsLost |
| 1152 |
Closing balance, financial liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
| 1153 |
101030 - Disclosure - Financial Instruments - Schedule of Derivative Swap Agreements (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsScheduleOfDerivativeSwapAgreementsDetails |
| 1154 |
Disclosure Of Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 1155 |
Classes of financial liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialLiabilitiesAxis |
| 1156 |
Financial liabilities, class [member] |
Member |
|
|
ifrs-full:FinancialLiabilitiesMember |
| 1157 |
Cross Currency Swap Contract |
Member |
|
|
ifrs-full:CurrencySwapContractMember |
| 1158 |
Interest Rate Swap Contract |
Member |
|
|
ifrs-full:InterestRateSwapContractMember |
| 1159 |
Disclosure Of Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 1160 |
Non-current asset |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentDerivativeFinancialAssets |
| 1161 |
Non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentDerivativeFinancialLiabilities |
| 1162 |
101040 - Disclosure - Financial Instruments - Schedule of Maturity Analysis Associated with Interest Rate Swap Agreement - Long-Term Debt (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsScheduleOfMaturityAnalysisAssociatedWithInterestRateSwapAgreementLongTermDebtDetails |
| 1163 |
Disclosure Of Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 1164 |
Classes of financial assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialAssetsAxis |
| 1165 |
Financial assets, class [member] |
Member |
|
|
ifrs-full:FinancialAssetsMember |
| 1166 |
Interest Rate Swap Contract |
Member |
|
|
ifrs-full:InterestRateSwapContractMember |
| 1167 |
Types of interest rates [axis] |
Axis |
|
|
ifrs-full:TypesOfInterestRatesAxis |
| 1168 |
Interest rate types [member] |
Member |
|
|
ifrs-full:InterestRateTypesMember |
| 1169 |
Fixed Rate |
Member |
|
|
ifrs-full:FixedInterestRateMember |
| 1170 |
Disclosure Of Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 1171 |
Loans and borrowings, Fixed rate |
Concept (Percent) |
As Of |
|
ifrs-full:BorrowingsInterestRate |
| 1172 |
Loans and borrowings, Notional amount |
Concept (Monetary) |
As Of |
|
ifrs-full:NotionalAmount |
| 1173 |
Loans and borrowings, Maturity |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsMaturity |
| 1174 |
Loans and borrowings, Long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 1175 |
101050 - Disclosure - Financial Instruments - Summary of Aging of Trade Receivable Balances (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfAgingOfTradeReceivableBalancesDetails |
| 1176 |
Disclosure Of Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 1177 |
Past due status [axis] |
Axis |
|
|
ifrs-full:PastDueStatusAxis |
| 1178 |
Past due status [member] |
Member |
|
|
ifrs-full:PastDueStatusMember |
| 1179 |
Current |
Member |
|
|
ifrs-full:CurrentMember |
| 1180 |
Past due 0-30 days |
Member |
|
|
ifrs-full:NotLaterThanOneMonthMember |
| 1181 |
Past due 31-120 days |
Member |
|
|
ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember |
| 1182 |
Past due over 121 days |
Member |
|
|
ifrs-full:LaterThanFourMonthsMember |
| 1183 |
Disclosure Of Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 1184 |
Trade receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentTradeReceivables |
| 1185 |
Less allowance for doubtful accounts |
Concept (Monetary) |
As Of |
Credit |
nept:AllowanceForDoubtfulTradeReceivables |
| 1186 |
Current Trade Receivables Net Of Allowance |
Concept (Monetary) |
As Of |
Debit |
nept:CurrentTradeReceivablesNetOfAllowance |
| 1187 |
101060 - Disclosure - Financial Instruments - Schedule of Movement of Trade Receivable Allowance for Doubtful Accounts (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsScheduleOfMovementOfTradeReceivableAllowanceForDoubtfulAccountsDetails |
| 1188 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1189 |
Disclosure Of Financial Instruments [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsAbstract |
| 1190 |
Balance, beginning of year |
Concept (Monetary) |
As Of |
Credit |
nept:AllowanceForDoubtfulTradeReceivables |
| 1191 |
Bad debt expenses |
Concept (Monetary) |
For Period |
Debit |
nept:BadDebtExpenseAllowanceForDoubtfulAccountsTradeReceivables |
| 1192 |
Foreign exchange (gain) loss |
Concept (Monetary) |
For Period |
Credit |
nept:ForeignExchangeGainOrLossAllowanceForDoubtfulAccountsTradeReceivables |
| 1193 |
Write-off against reserve |
Concept (Monetary) |
For Period |
Credit |
nept:WriteOffsRecoveriesOnReservesAllowanceForDoubtfulAccountsTradeReceivables |
| 1194 |
Balance, end of year |
Concept (Monetary) |
As Of |
Credit |
nept:AllowanceForDoubtfulTradeReceivables |
| 1195 |
101070 - Disclosure - Financial Instruments - Summary of Effect of Changes in Foreign Exchange Currency (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfEffectOfChangesInForeignExchangeCurrencyDetails |
| 1196 |
Disclosure Of Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 1197 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
| 1198 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
| 1199 |
Foreign Exchange Rate Risk |
Member |
|
|
nept:ForeignExchangeRateRiskMember |
| 1200 |
Currency |
Axis |
|
|
us-gaap:CurrencyAxis |
| 1201 |
All Currencies |
Member |
|
|
currency:AllCurrenciesDomain |
| 1202 |
U S Dollars |
Member |
|
|
nept:USDollarsMember |
| 1203 |
Euro |
Member |
|
|
nept:EuroMember |
| 1204 |
GBP |
Member |
|
|
nept:GreatBritainPoundMember |
| 1205 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
| 1206 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
| 1207 |
5% Strengthening of Currency |
Member |
|
|
nept:FivePercentageStrengtheningOfCurrencyMember |
| 1208 |
Disclosure Of Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 1209 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
| 1210 |
Trade and other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherReceivables |
| 1211 |
Trade and other payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherPayables |
| 1212 |
Long-term payable |
Concept (Monetary) |
As Of |
Credit |
nept:LongTermPayable |
| 1213 |
Derivative financial liability swap |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DerivativeFinancialLiabilities |
| 1214 |
Long-term debt |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
| 1215 |
Financial assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssets |
| 1216 |
Average |
Concept (Decimal) |
For Period |
|
ifrs-full:AverageForeignExchangeRate |
| 1217 |
Reporting |
Concept (Decimal) |
As Of |
|
ifrs-full:ClosingForeignExchangeRate |
| 1218 |
Increase in net profit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss |
| 1219 |
101080 - Disclosure - Financial Instruments - Summary of Corporation's Exposure to Interest Rate Risk (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfCorporationSExposureToInterestRateRiskDetails |
| 1220 |
Disclosure Of Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 1221 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
| 1222 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
| 1223 |
Interest rate risk [member] |
Member |
|
|
ifrs-full:InterestRateRiskMember |
| 1224 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 1225 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 1226 |
Cash and Cash Equivalents |
Member |
|
|
us-gaap:CashAndCashEquivalentsMember |
| 1227 |
Restricted Short-term Investments |
Member |
|
|
ifrs-full:ShorttermBorrowingsMember |
| 1228 |
Long-term Debt |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
| 1229 |
Unsecured Convertible Debentures |
Member |
|
|
nept:UnsecuredConvertibleDebenturesMember |
| 1230 |
Disclosure Of Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 1231 |
Borrowings, interest rate basis |
Concept (Text/String) |
For Period |
|
ifrs-full:BorrowingsInterestRateBasis |
| 1232 |
101090 - Disclosure - Financial Instruments - Summary of Contractual Maturities of Financial Liabilities (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureFinancialInstrumentsSummaryOfContractualMaturitiesOfFinancialLiabilitiesDetails |
| 1233 |
Disclosure Of Financial Instruments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
| 1234 |
Types of risks [axis] |
Axis |
|
|
ifrs-full:TypesOfRisksAxis |
| 1235 |
Risks [member] |
Member |
|
|
ifrs-full:TypesOfRisksMember |
| 1236 |
Liquidity Risk |
Member |
|
|
ifrs-full:LiquidityRiskMember |
| 1237 |
Borrowings by name [axis] |
Axis |
|
|
ifrs-full:BorrowingsByNameAxis |
| 1238 |
Borrowings by name [member] |
Member |
|
|
ifrs-full:BorrowingsByNameMember |
| 1239 |
Trade and Other Payables And Long-term Payable |
Member |
|
|
nept:TradeAndOtherPayablesAndLongTermPayableMember |
| 1240 |
Long-term Debt |
Member |
|
|
ifrs-full:LongtermBorrowingsMember |
| 1241 |
Unsecured Convertible Debentures |
Member |
|
|
nept:UnsecuredConvertibleDebenturesMember |
| 1242 |
Interest Rate Swap Contract |
Member |
|
|
ifrs-full:InterestRateSwapContractMember |
| 1243 |
Cross Currency Swap Contract |
Member |
|
|
ifrs-full:CurrencySwapContractMember |
| 1244 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 1245 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 1246 |
Less than 1 year |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 1247 |
1 to 5 years |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember |
| 1248 |
More than 5 years |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
| 1249 |
Disclosure Of Financial Instruments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
| 1250 |
Carrying amount |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:FinancialLiabilities |
| 1251 |
Contractual cash flows |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows |
| 1252 |
101100 - Disclosure - Operating Leases - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOperatingLeasesAdditionalInformationDetails |
| 1253 |
Operating Leases [Table] |
Table |
* |
* |
nept:OperatingLeasesTable |
| 1254 |
Arrangements involving legal form of lease [axis] |
Axis |
|
|
ifrs-full:ArrangementsInvolvingLegalFormOfLeaseAxis |
| 1255 |
Arrangements involving legal form of lease [member] |
Member |
|
|
ifrs-full:ArrangementsInvolvingLegalFormOfLeaseMember |
| 1256 |
Lease One |
Member |
|
|
nept:LeaseOneMember |
| 1257 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 1258 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 1259 |
Bottom of range |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 1260 |
Top of range |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 1261 |
Income Statement Location1 |
Axis |
|
|
nept:IncomeStatementLocation1Axis |
| 1262 |
Income Statement Location1 Member |
Member |
|
|
nept:IncomeStatementLocation1Member |
| 1263 |
Selling, general and administrative expenses |
Member |
|
|
nept:SellingGeneralAndAdministrativeExpenseMember |
| 1264 |
Cost of sales |
Member |
|
|
nept:CostOfSales1Member |
| 1265 |
Research and development expenses |
Member |
|
|
nept:ResearchAndDevelopmentExpensesMember |
| 1266 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
| 1267 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
| 1268 |
Less than 1 year |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
| 1269 |
2020 |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember |
| 1270 |
2021 |
Member |
|
|
ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember |
| 1271 |
2022 |
Member |
|
|
ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember |
| 1272 |
2023 |
Member |
|
|
ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember |
| 1273 |
Operating Leases [Line Items] |
LineItems |
|
|
nept:OperatingLeasesLineItems |
| 1274 |
Operating lease expiration terms |
Concept (Date) |
For Period |
|
nept:OperatingLeaseExpirationTerms |
| 1275 |
Minimum operating lease payments recognised as expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:MinimumOperatingLeasePayments |
| 1276 |
Operating costs of lease |
Concept (Monetary) |
For Period |
Debit |
nept:OperatingCostsOfLease |
| 1277 |
Tax on lease |
Concept (Monetary) |
For Period |
Debit |
nept:TaxOnLease |
| 1278 |
Minimum lease payments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease |
| 1279 |
101110 - Disclosure - Commitments and Contingencies - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails |
| 1280 |
Disclosure Of Commitments And Contingencies [Table] |
Table |
* |
* |
nept:DisclosureOfCommitmentsAndContingenciesTable |
| 1281 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
| 1282 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
| 1283 |
Bottom of range |
Member |
|
|
ifrs-full:BottomOfRangeMember |
| 1284 |
Top of range |
Member |
|
|
ifrs-full:TopOfRangeMember |
| 1285 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 1286 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 1287 |
CEO |
Member |
|
|
nept:CEOMember |
| 1288 |
Disclosure Of Commitments And Contingencies [Line Items] |
LineItems |
|
|
nept:DisclosureOfCommitmentsAndContingenciesLineItems |
| 1289 |
Term of minimum annual volume of sales to maintain exclusivity of speciality ingredient |
Concept (xbrli:durationItemType) |
For Period |
|
nept:TermOfMinimumAnnualVolumeOfSalesToMaintainExclusivityOfSpecialityIngredient |
| 1290 |
Total remaining amount of royalties |
Concept (Monetary) |
As Of |
Credit |
nept:RemainingRoyaltyCommitments |
| 1291 |
Capital expenditure obligations |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ContractualCapitalCommitments |
| 1292 |
Capital expenditure |
Concept (Monetary) |
For Period |
Credit |
nept:CapitalExpenditureCommitments |
| 1293 |
Capital expenditure included in trade and other payables |
Concept (Monetary) |
As Of |
Credit |
nept:CapitalExpenditureIncludedInTradeAndOtherPayables |
| 1294 |
Payment of capital expenditure |
Concept (Monetary) |
For Period |
Debit |
nept:PaymentOfCapitalExpenditure |
| 1295 |
Capital commitments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CapitalCommitments |
| 1296 |
Capital commitment included in trade and other payable |
Concept (Monetary) |
As Of |
Credit |
nept:CapitalCommitmentIncludedInTradeAndOtherPayable |
| 1297 |
Payment of capital commitments |
Concept (Monetary) |
For Period |
Credit |
nept:PaymentOfCapitalCommitments |
| 1298 |
Research and development projects, remaining amount |
Concept (Monetary) |
As Of |
Debit |
nept:ResearchAndDevelopmentProjectsRemainingAmount |
| 1299 |
Claims by former CEO |
Concept (Monetary) |
As Of |
Credit |
nept:ContingentLiability |
| 1300 |
Provisions recognized on claims |
Concept (Monetary) |
As Of |
Debit |
nept:ProvisionsRecognized |
| 1301 |
Percentage of royalties payable |
Concept (Percent) |
For Period |
|
nept:PercentageOfRoyaltiesPayable |
| 1302 |
Amount owed from customer |
Concept (Monetary) |
For Period |
Debit |
nept:AmountOwedFromCustomer |
| 1303 |
101120 - Disclosure - Capital Management - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalManagementAdditionalInformationDetails |
| 1304 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1305 |
Capital Management [Abstract] |
Abstract |
|
|
nept:CapitalManagementAbstract |
| 1306 |
Cash |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Cash |
| 1307 |
Cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashEquivalents |
| 1308 |
101130 - Disclosure - Capital Management - Summary of Cash Equivalents and Restricted Short-term Investments (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureCapitalManagementSummaryOfCashEquivalentsAndRestrictedShortTermInvestmentsDetails |
| 1309 |
Disclosure Of Capital Management [Table] |
Table |
* |
* |
nept:DisclosureOfCapitalManagementTable |
| 1310 |
Classes of assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfAssetsAxis |
| 1311 |
Assets [member] |
Member |
|
|
ifrs-full:ClassesOfAssetsMember |
| 1312 |
Term Deposits One |
Member |
|
|
nept:TermDepositsOneMember |
| 1313 |
Term Deposits Two |
Member |
|
|
nept:TermDepositsTwoMember |
| 1314 |
Classes of financial assets [axis] |
Axis |
|
|
ifrs-full:ClassesOfFinancialAssetsAxis |
| 1315 |
Financial assets, class [member] |
Member |
|
|
ifrs-full:FinancialAssetsMember |
| 1316 |
Cross Currency Swap |
Member |
|
|
nept:CrossCurrencySwapMember |
| 1317 |
Business combinations [axis] |
Axis |
|
|
ifrs-full:BusinessCombinationsAxis |
| 1318 |
Entity's total for business combinations [member] |
Member |
|
|
ifrs-full:EntitysTotalForBusinessCombinationsMember |
| 1319 |
Biodroga Nutraceuticals Inc |
Member |
|
|
nept:BiodrogaNutraceuticalsIncMember |
| 1320 |
Disclosure Of Capital Management [Line Items] |
LineItems |
|
|
nept:DisclosureOfCapitalManagementLineItems |
| 1321 |
Maturity dates of term deposits |
Concept (Date) |
For Period |
|
nept:TermDepositsMaturityDates |
| 1322 |
Term deposits interest rate |
Concept (Percent) |
For Period |
|
nept:TermDepositsInterestRate |
| 1323 |
Cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashEquivalents |
| 1324 |
Restricted short-term investments maturity date |
Concept (Date) |
For Period |
|
nept:RestrictedShortTermInvestmentsMaturityDate |
| 1325 |
Restricted short-term investments interest rate |
Concept (Percent) |
For Period |
|
nept:RestrictedShortTermInvestmentsInterestRate |
| 1326 |
Restricted short-term investments |
Concept (Monetary) |
As Of |
Debit |
nept:RestrictedShortTermInvestments |
| 1327 |
101140 - Disclosure - Operating segments - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOperatingSegmentsAdditionalInformationDetails |
| 1328 |
Disclosure Of Operating Segments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
| 1329 |
Major customers [axis] |
Axis |
|
|
ifrs-full:MajorCustomersAxis |
| 1330 |
Customers [member] |
Member |
|
|
ifrs-full:MajorCustomersMember |
| 1331 |
Major Customer One |
Member |
|
|
nept:MajorCustomerOneMember |
| 1332 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 1333 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 1334 |
Nutraceutical |
Member |
|
|
nept:NutraceuticalMember |
| 1335 |
Disclosure Of Operating Segments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
| 1336 |
Description of factors used to identify entity's reportable segments |
Concept (Text/String) |
For Period |
|
ifrs-full:FactorsUsedToIdentifyEntitysReportableSegments |
| 1337 |
Number of Segments |
Concept (Integer) |
For Period |
|
nept:NumberOfSegments |
| 1338 |
Revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
| 1339 |
Number of customers representing ten percent or more of sales |
Concept (Integer) |
For Period |
|
nept:NumberOfCustomersRepresentingTenPercentOrMoreOfSales |
| 1340 |
Percentage of entity's revenue |
Concept (Percent) |
For Period |
|
ifrs-full:PercentageOfEntitysRevenue |
| 1341 |
101150 - Disclosure - Operating segments - Summary of Information About Reportable Segments (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOperatingSegmentsSummaryOfInformationAboutReportableSegmentsDetails |
| 1342 |
Disclosure Of Operating Segments [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
| 1343 |
Segment consolidation items [axis] |
Axis |
|
|
ifrs-full:SegmentConsolidationItemsAxis |
| 1344 |
Entity's total for segment consolidation items [member] |
Member |
|
|
ifrs-full:EntitysTotalForSegmentConsolidationItemsMember |
| 1345 |
Intersegment Elimination |
Member |
|
|
ifrs-full:EliminationOfIntersegmentAmountsMember |
| 1346 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
| 1347 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
| 1348 |
Nutraceutical |
Member |
|
|
nept:NutraceuticalMember |
| 1349 |
Cannabis |
Member |
|
|
nept:CannabisMember |
| 1350 |
Cardiovascular |
Member |
|
|
nept:CardiovascularMember |
| 1351 |
Disclosure Of Operating Segments [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
| 1352 |
Revenue from external sales and royalties |
Concept (Monetary) |
For Period |
Credit |
nept:RevenueFromExternalSalesAndRoyalties |
| 1353 |
Revenue from transactions to Cardiovascular segment |
Concept (Monetary) |
For Period |
Credit |
nept:RevenueFromTransactionsToCardiovascularSegment |
| 1354 |
Gross margin |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
| 1355 |
Research and development expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
| 1356 |
Research tax credits and grants |
Concept (Monetary) |
For Period |
Credit |
nept:ResearchTaxCreditsAndGrants |
| 1357 |
Selling, general and administrative expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
| 1358 |
Other income – net gain on sale of assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnDisposalsOfNoncurrentAssets |
| 1359 |
Other income – royalty settlement |
Concept (Monetary) |
For Period |
Credit |
nept:OtherIncomeFromRoyaltySettlements |
| 1360 |
Income from operating activities |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
| 1361 |
Gain on loss of control of subsidiary |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesRecognisedWhenControlInSubsidiaryIsLost |
| 1362 |
Finance income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncome |
| 1363 |
Finance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
| 1364 |
Change in fair value of derivative assets and liabilities and loss on sale of available-for-sale investment |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseInDerivativeAssetAndLiabilitiesAndLossOnSaleOfAvailableForSaleInvestment |
| 1365 |
Change in fair value of derivative assets and liabilities |
Concept (Monetary) |
For Period |
Credit |
nept:IncreaseDecreaseInDerivativeAssetAndLiabilities |
| 1366 |
Income before income taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
| 1367 |
Income taxes (expense) recovery |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
| 1368 |
Net income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
| 1369 |
Depreciation and amortization |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DepreciationAndAmortisationExpense |
| 1370 |
Stock-based compensation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
| 1371 |
Reportable segment assets |
Concept (Monetary) |
As Of |
Debit |
nept:ReportableSegmentAssets |
| 1372 |
Reportable segment liabilities |
Concept (Monetary) |
As Of |
Credit |
nept:ReportableSegmentLiabilities |
| 1373 |
101160 - Disclosure - Operating segments - Summary of Revenue from Sales Based on Destination (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureOperatingSegmentsSummaryOfRevenueFromSalesBasedOnDestinationDetails |
| 1374 |
Disclosure Of Geographical Areas [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfGeographicalAreasTable |
| 1375 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
| 1376 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
| 1377 |
Canada |
Member |
|
|
country:CA |
| 1378 |
United States |
Member |
|
|
country:US |
| 1379 |
Belgium |
Member |
|
|
country:BE |
| 1380 |
China |
Member |
|
|
country:CN |
| 1381 |
France |
Member |
|
|
country:FR |
| 1382 |
Uruguay |
Member |
|
|
country:UY |
| 1383 |
Other Countries |
Member |
|
|
nept:OtherCountriesMember |
| 1384 |
Disclosure Of Geographical Areas [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfGeographicalAreasLineItems |
| 1385 |
Inventory sold |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromSaleOfGoods |
| 1386 |
101170 - Disclosure - Related Parties - Additional Information (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails |
| 1387 |
Disclosure Of Transactions Between Related Parties [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 1388 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 1389 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 1390 |
Key Management Personnel |
Member |
|
|
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember |
| 1391 |
Disclosure Of Transactions Between Related Parties [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 1392 |
Proportion of voting rights |
Concept (Percent) |
For Period |
|
nept:ProportionOfVotingRights |
| 1393 |
101180 - Disclosure - Related Parties - Summary of Key Management Personnel Compensation (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureRelatedPartiesSummaryOfKeyManagementPersonnelCompensationDetails |
| 1394 |
Implied Table |
Table |
* |
* |
implied:Table |
| 1395 |
Disclosure Of Transactions Between Related Parties [Abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
| 1396 |
Short-term benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits |
| 1397 |
Share-based compensation costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment |
| 1398 |
Total compensation of key management personnel |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensation |
| 1399 |
101190 - Disclosure - Related Parties - Summary of Key Management Personnel Compensation (Parenthtical) (Details) |
Network |
* |
* |
http://www.neptunebiotech.com/20180331/taxonomy/role/DisclosureRelatedPartiesSummaryOfKeyManagementPersonnelCompensationParenthticalDetails |
| 1400 |
Disclosure Of Transactions Between Related Parties [Table] |
Table |
* |
* |
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesTable |
| 1401 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
| 1402 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
| 1403 |
Acasti |
Member |
|
|
nept:AcastiMember |
| 1404 |
Disclosure Of Transactions Between Related Parties [Line Items] |
LineItems |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesLineItems |
| 1405 |
Short-term benefits |
Concept (Monetary) |
For Period |
Debit |
nept:KeyManagementPersonnelCompensationShortTermEmployeeBenefits1 |
| 1406 |
Share-based compensation costs |
Concept (Monetary) |
For Period |
Debit |
nept:KeyManagementPersonnelCompensationShareBasedPayment1 |